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 Foreword 
 
 
This Ph.D. thesis is based on the results published in international, peer-reviewed, scientific 
journals. It is presented in three chapters: the first chapter gives an introduction to the entire 
work and the following two chapters correspond to the published papers.  
   
   
Table of Contents 
 
Summary          07 
Zusammenfassung         10 
General Introduction        13 
IGF-I system          13 
     Overview          13 
     IGF-I          15 
     IGF-IR          17 
     IGF-Binding Proteins        20 
IGF-I function in fish         22 
     Growth          22 
     Development         22 
     Osmoregulation         23 
     Reproduction         24 
Tilapia model system         25 
Aims of the study         28 
References          29 
Chapter 1          45 
Organ-specific expression of IGF-I during early development of bony fish as 
revealed in the tilapia, Oreochromis niloticus, by in situ hybridization and 
immunohistochemistry: indication for the particular importance of local IGF-I 
Introduction          46 
Materials and Methods        47 
Results          51 
Discussion          64 
References          72 
   
 Chapter 2          82 
Differential expression of IGF-I mRNA and peptide in the male and female 
gonad during early development of a bony fish, the tilapia Oreochromis 
niloticus 
Introduction          83 
Materials and Methods        84 
Results          87 
Discussion          93 
References          96 
Publications          101 
Acknowledgments         106 
 
   
Summary 
 
Insulin-like growth factor I (IGF-I) plays a key role in the complex system that regulates 
vertebrate growth, differentiation and reproduction. The major source of endocrine IGF-I is 
the liver, which synthesizes and secretes IGF-I after stimulation by growth hormone (GH) 
from the anterior pituitary. Circulating IGF-I binds to specific receptors at peripheral sites and 
exert its physiological effects. In mammals, IGF-I is also synthesised in various organs and 
has the ability to act in a paracrine or an autocrine manner in addition to the endocrine route.  
In order to get a first impression of the potential local actions of IGF-I during 
ontogeny, it is important to know the IGF-I synthesis sites. The present study approaches this 
problem by investigating the dynamics of IGF-I expression during early development of the 
bony fish Oreochromis niloticus, the Nile tilapia. O. niloticus is a major commercial tropical 
fish, cultured in increasing numbers throughout the world and, therefore, any insight in the 
regulation of its ontogeny is of special importance. The studies were carried out with monosex 
progenies of O. niloticus, in the early stages of development starting from the day of hatching, 
i.e. at 4 days post fertilization (DPF), until the adult life. Specific antisera raised against 
human IGF-I and a fluorescent detection system were used to investigate IGF-I peptide 
localisation. IGF-I mRNA was detected by digoxigenin labelled RNA probes complementary 
to tilapia IGF-I mRNA sequence and nitroblue tetrazolium colour reaction. Crossreactivity 
and specificity of binding were verified for both antisera and RNA probes. 
 In liver, IGF-I mRNA was expressed already at the day of hatching, 4 DPF, indicating 
the physiological impact of circulating IGF-I during development.  
IGF-I also appeared very early in tissues which are highly involved in growth, such as 
cartilage and skeletal muscle. At 4 DPF, IGF-I mRNA and peptide were already present in 
chondrocytes of cartilage of various locations, with increasing intensity towards the growing 
regions, and also found in adults. The onset of IGF-I production in skeletal muscle was also at 
4 DPF. It showed a maximum around 10-29 DPF, decreased later but persisted throughout 
life. 
In the gastro-intestinal tract it was expressed at 5 DPF in the intestine and at 9 DPF in 
the stomach. During the first weeks of development, the IGF-I-immunoreactive material was 
mainly located in the apex of epithelial cells, possibly suggesting its release into the lumen. 
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Around 17 DPF, additional IGF-I containing mucosal cells appeared which showed the 
typical appearance of endocrine cells. These persisted throughout life. In the exocrine 
pancreas, the expression of IGF-I started at 4 DPF and occurred until 90 DPF. IGF-I was 
found in non-insulin cells of endocrine pancreas from 6 DPF as well as during adult life.  
In the gills, IGF-I mRNA appeared in chloride cells at 6 DPF. The early appearance of 
IGF-I may suggest that it exerts functions, such as to influence growth and maintenance of the 
filament epithelium, in addition to its impact in the regulation of plasma osmolality and gill 
Na+, K+-ATPase activity as described in adult fish. In the kidney, that is also involved in 
osmoregulation, IGF-I production started at 8 DPF in epithelial cells of renal tubules and 
ducts and persisted until adult age. 
In the heart, IGF-I mRNA and peptide appeared at 13 DPF in cardiomyocytes. The 
expression of IGF-I was detectable until 70 DPF but absent from later stages and adults 
indicating a particular physiological impact of IGF-I during heart development and growth.  
IGF-I appeared in epidermal cells at 5 DPF. The number of IGF-I producing cells first 
increased with age reaching the highest level around 19-29 DPF. Later some superficial and 
basal epidermal cells exhibited IGF-I mRNA likely suggesting that IGF-I in skin is not only 
involved in proliferation but also in repair mechanisms and wound healing. 
IGF-I mRNA was expressed in virtually all neurons of brain and ganglia from 6 to 29 
DPF, their number decreasing with age. IGF-I immunoreactivity was detected in 
neurohypophysis at 17 DPF and in adenohypophysis at 40 DPF, while the mRNA appeared 
only in adenohypophysis at 28 DPF. Thus, IGF-I in the neuropituitary likely originates from 
neuronal perikarya within the hypothalamus which exhibited IGF-I-immunoreactivity. 
In the male and female gonad anlagen, IGF-I mRNA was detectable in somatic cells 
already after its first appearance around 7 DPF, followed by the peptide at 9-10 PDF. In 
undifferentiated primordial germ cells IGF-I peptide, but not mRNA, was detected at 7 DPF, 
suggesting that it may be derived from somatic cells or be of maternal origin. IGF-I mRNA 
appeared at 29 DPF in female and around 51-33 DPF in male germ cells, which coincides 
with the onset of meioses in tilapia ovaries and testis. In adult testis, IGF-I mRNA and peptide 
occurred in spermatogonia and spermatocytes and in Leydig cells, the latter indicating a role 
of IGF-I in the synthesis of male sex steroids. In adult ovary, IGF-I mRNA and IGF-I peptide 
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were present in small and previtellogenic oocytes and occurred in granulosa and theca cells of 
later follicles.  
 Thus, while liver synthesizes IGF-I throughout life, in parenchymal cells of most 
organs investigated, such as epithelial cells of the gastro-intestinal tract, acinar cells of the 
exocrine pancreas, skeletal muscle cells, cardiomyocytes, renal tubular and duct cells, 
neurones of the central and peripheral nervous system, and skin cells the expression of IGF-I 
was more pronounced during ontogeny than in juvenile and adult life. These results suggest a 
high functional impact of local IGF-I in early fish organogenesis, growth and metabolism by 
auto/paracrine means of regulation. The findings, thus, support the idea of a dual mode of 
action for IGF-I: as endocrine hormone and as local para/autocrine hormone. 
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Zusammenfassung 
 
Insulin-like growth factor I (IGF-I)  spielt eine Schlüsselrolle bei der komplexen Regulation 
des Wachstums, der Differenzierung und der Vermehrung der Wirbeltiere. Die Hauptquelle 
des endokrinen IGF-I ist die Leber. Nach Stimulation durch Wachstumshormon aus dem 
Hypophysenvorderlappen synthetisiert und sezerniert die Leber IGF-I. Das zirkulierende IGF-
I bindet in der Peripherie an spezifische Rezeptoren und ruft so seine physiologischen 
Wirkungen hervor. Bei Säugern wird IGF-I darüber hinaus auch in zahlreichen anderen 
Organen gebildet und kann zusätzlich zu seiner endokrinen Wirkung auch parakrine und 
autokrine Wirkungen hervorrufen. 
 Um eine Vorstellung von den möglichen lokalen IGF-I-Wirkungen während der 
Ontogenese zu erhalten,  ist es wichtig, die Syntheseorte von IGF-I zu kennen. In der  
vorliegenden Studie wird daher die Dynamik der IGF-I-Expression während der frühen 
Entwicklung des Knochenfisches Oreochromis niloticus, der Nil-Tilapia, untersucht. O. 
niloticus ist ein tropischer Fisch von wirtschaftlicher Bedeutung, der weltweit in 
zunehmenden Mengen  gezüchtet wird. Kenntnisse über die Regulation der Ontogenese sind 
daher von speziellem Interesse. Die Studien wurden an Nachkommen gleichen Geschlechts 
vom Tag des Schlüpfens, i.e. vom 4. Tag nach der Fertilisierung (DPF), bis zum 
Erwachsenenalter durchgeführt. Für die Gewebslokalisation  von IGF-I Peptid wurde eine 
Fluoreszenzmethode mit spezifischen Antiseren gegen menschliches IGF-I benutzt. IGF-I 
mRNA  wurde mit  Digoxigenin-markierten RNA Proben von komplementärer  Sequenz zur 
Tilapia IGF-I mRNA und durch eine Farbreaktion mit Nitroblau-Tetrazolium nachgewiesen. 
Sowohl für Antiseren als auch für RNA Proben wurden Kreuzreaktivität und Spezifität 
getestet. 
 In der Leber wurde IGF-I mRNA bereits am Tag des Schlüpfens, 4 Tage nach der 
Fertilisation, exprimiert, ein Hinweis darauf, dass zirkulierendes IGF-I bereits während der 
frühen Entwicklung von Bedeutung ist.  
 IGF-I  erschien auch schon früh im Knorpel und  im Skelettmuskel.  So waren IGF-I 
Peptid und IGF-I mRNA bereits 4 Tage nach Fertilisation in Chondrozyten verschiedener 
Knorpelgewebe nachweisbar, und zwar mit zunehmender Intensität zu den Wachstumszonen 
des Knorpels hin. Auch im Skelettmuskel begann die IGF-I Produktion am 4. Tag nach der 
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Fertilisation. Das Maximum lag zwischen dem 10. und 29. Tag nach Fertilisation. Später fiel 
die IGF-I Produktion ab, hielt jedoch  während der gesamten Lebensspanne an.  
 Innerhalb des Magen-Darm-Trakts wurde IGF-I im Darm am 5., im Magen am 9.Tag 
nach der Fertilisation exprimiert. Während der ersten Wochen der Entwicklung war 
immunreaktives  IGF-I vorwiegend an der apikalen Seite der Epithelzellen lokalisiert, 
möglicherweise ein Hinweis auf seine Freisetzung ins Lumen. Um den 17. Tag nach 
Fertilisation erschienen zusätzlich IGF-I enthaltende Mucosazellen, die das typische 
Aussehen endokriner Zellen zeigten. Diese Zellen blieben während der gesamten 
Lebensspanne bestehen. Im exokrinen Pankreas war die  IGF-I-Expression vom 4. bis zum 
90. Tag nach Fertilisation nachweisbar. IGF-I wurde ab dem 6. Tag nach Fertilisation  in nicht 
Insulin-produzierenden Zellen des endokrinen Pankreas gefunden, ebenso im 
Erwachsenenalter. 
 In den Kiemen erschien IGF-I mRNA am 6. Tag nach Fertilisation in den 
Chloridzellen. Dieses frühe Auftreten könnte darauf hinweisen, dass IGF-I nicht nur für die 
Regulation der Plasmaosmolalität und die Aktivität der Na+, K+ -ATPase der Kiemen, wie bei 
erwachsenen Fischen beschrieben, nötig ist, sondern auch für das Wachstum und die 
Aufrechterhaltung des Filamentepithels. In der Niere, die ebenfalls an der Osmoregulation 
beteiligt ist, begann die IGF-I Produktion 8 Tage nach der Fertilisation in Epithelzellen der 
Nierentubuli und Sammelrohre und hielt bis zum Erwachsenenalter an. 
 Im Herz erschienen IGF-I mRNA und Peptid 13 Tage nach Fertilisation in den 
Kardiomyozyten. Die Expression bestand bis zum 70. Tag nach Fertilisation, fehlte jedoch 
später und im Erwachsenenalter. Möglicherweise weist dies auf eine spezielle physiologische 
Rolle während Herzentwicklung und Herzwachstums hin. 
 In Epidermiszellen trat IGF-I am 5. Tag nach der Fertilisation auf. Zunächst nahm die 
Zahl der IGF-I- immunreaktiven Zellen mit dem Alter zu und erreichte ein Maximum 
zwischen dem 19. und 29. Tag nach der Fertilisation. Später enthielten einige oberflächliche 
und basale epidermale Zellen IGF-I mRNA,  wahrscheinlich ein Hinweis darauf, dass IGF-I 
in der Haut nicht nur die Zellproliferation stimuliert, sondern auch an Reparaturmechanismen 
und an der Wundheilung beteiligt ist.  
 IGF-I mRNA wurde vom 6. bis zum 29. Tag nach Fertilisation in praktisch allen 
Neuronen des Gehirns und der Ganglien exprimiert, wobei die Zahl der IGF-I exprimierenden 
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Zellen mit dem Alter abnahm. In der Neurohypophyse war immunoreaktives IGF-I am 17., in 
der Adenohypophyse am 40. Tag nach Fertilisation nachweisbar, während die IGF-I mRNA 
nur in der Adenohypophyse am 28. Tag nach Fertilisation erschien. Daher stammt das IGF-I 
in der Neurohypophyse wahrscheinlich aus neuronalen Perikaryen im Hypothalamus, die 
immunreaktives IGF-I aufwiesen. 
 In der männlichen und weiblichen Gonadenanlage war IGF-I mRNA in den 
somatischen Zellen bereits kurz nach deren Erscheinen um den 7. Tag nach Fertilisation 
nachweisbar, IGF-I Peptid an den Tagen 9-10. In undifferenzierten primordialen Keimzellen 
war IGF-I Peptid, nicht aber IGF-I mRNA, am Tag 7 nach Fertilisation nachzuweisen, ein 
Hinweis darauf, dass es aus somatischen Zellen stammt oder mütterlichen Ursprungs ist. IGF-
I mRNA erschien am 29. Tag nach Fertilisation in weiblichen und zwischen dem 51. und  53. 
Tag in männlichen Keimzellen, und damit gleichzeitig mit dem Beginn der Meiose in den 
Ovarien und Hoden. In den Hoden erwachsener Tiere fanden sich IGF-I mRNA und IGF-I 
Peptid in Spermatogonien, Spermatozyten und Leydig’schen Zwischenzellen. Letzterer 
Befund dürfte auf eine Rolle von IGF-I bei der Synthese männlicher Sexsteroide hindeuten. 
Im Ovar erwachsener Tiere lagen IGF-I mRNA und IGF-I Peptid in kleinen und 
prävitellogenen Oozyten vor,  in späteren Follikelstadien in Granulosa- und Thekazellen. 
 Zusammenfassend lässt sich folgendes festhalten: Während die Leber über die 
gesamte Lebensspanne IGF-I synthetisiert, war die Expression von IGF-I in den 
Parenchymzellen der meisten untersuchten Organe -  so in den Epithelzellen des Magen-
Darm-Trakts, in den Azinuszellen des exokrinen Pankreas, in den Skelettmuskelzellen und 
den Kardiomyozyten, in den Nierentubulus- und Sammelrohrzellen, in den Neuronen des 
zentralen und peripheren Nervensystems und in Hautzellen -  während der Ontogenese stärker 
ausgeprägt als im juvenilen und Erwachsenenzustand. Diese Befunde sprechen für eine 
zweifache Wirkungsweise von IGF-I: die eines endokrinen und die eines auto/parakrinen 
Hormons. 
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General Introduction 
 
 
IGF-I system 
 
Overview 
 
Insulin-like growth factor-I (IGF-I) is a member of the insulin/IGF-I family of hormones that 
play an important role in metabolism, growth and development. The insulin/IGF-I family is 
comprised of ligands (insulin, IGF-I and IGF-II), six well characterized binding proteins 
(IGFBP-1 through -6), and cell surface receptors that mediate the actions of the ligands 
(insulin receptor, IGF-I receptor and the IGF-II receptor, that is the mannose-6-phosphate 
[M6P] receptor with additional IGF-II binding site) (Fig. 1). 
 The IGFs were originally identified in 1957 by their ability to stimulate 35S 
incorporation into rat cartilage and termed “sulfation factor” (Salmon and Daughaday, 1957). 
Experiments in vivo as well as in vitro demonstrated the existence of an intermediate 
component responsible for the incorporation of 35S in the epiphyseal cartilage after the 
stimulation by growth hormone (GH) (Denko and Bergenstal, 1955; Murphy et al., 1956; 
Daughaday and Reeder, 1966). Subsequent studies expanded the spectrum of biological 
actions of the sulfation factors, including insulin-like activity that could not be neutralized by 
antisera against insulin (Froesch et al., 1963), and mitogenic effects on HeLa cells (Salmon 
and Hosse, 1971) and embryo fibroblasts (Dulak and Temin, 1973b; Dulak and Temin, 
1973a). In the light of these and other findings the new term “somatomedin” was proposed in 
1972 (Daughaday et al., 1972), denoting that this compounds mediated effects of GH. 
 Purification yielded a GH-responsive fraction, somatomedin C and non-responsive 
somatomedin A. In 1978, the active substances were isolated and sequenced from human 
serum (Rinderknecht and Humbel, 1976; Rinderknecht and Humbel, 1978a; Rinderknecht and 
Humbel, 1978b). They were named insulin-like growth factors (IGFs) on the basis of their 
functional (glucose uptake by fat cells and muscles) and sequence (approximately 50% amino 
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acid sequence) similarity to insulin. As it became clear that the somatomedins were a part of a 
larger superfamily of proteins, the more appropriate term IGF was adopted (Daughaday et al., 
1987). 
 
 
 
Fig. 1 The IGF family and related signaling molecules (Dupont and Holzenberger, 2003). 
 
Liver is the main source of circulating IGF-I. Under the regulation of GH IGF-I is synthesized 
and secreted from the liver into the circulation and acts on numerous peripheral tissues and 
cell types, exerting metabolic and mitogenic actions. This is known as the somatomedin 
hypothesis, which states that growth-promoting function of GH is mediated by IGF-I. 
Circulating IGF-I also provides a negative feedback on GH secretion from the anterior 
pituitary gland (Berelowitz et al., 1981). 
 In addition to its endocrine mechanism of action, IGF-I also acts in local autocrine or 
paracrine manners. This mode of IGF-I action is apparent from observations that IGF-I is 
produced in numerous extrahepatic sites (D'Ercole et al., 1980; Roberts et al., 1987; Han et 
al., 1988), and by the fact that even a 75% reduction of circulating IGF-I has little effect on 
postnatal growth in mice (Sjogren et al., 1999; Yakar et al., 1999). Although locally produced 
IGF-I may be regulated by other factors as well, GH was shown to affect its production in 
several organs (Lowe et al., 1987; Lowe et al., 1988). It is not yet entirely clear what is the 
importance of local versus circulating IGF-I, and what are the exact mechanisms of regulation 
of IGF-I action. 
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IGF-I 
 
General 
Structurally, the IGFs belong to the insulin superfamily of polypeptides which also includes 
insulin, relaxins, and a number of insulin-like proteins (INSL) identified in vertebrates and 
invertebrates, including, 7 drosophila insulin-like peptides, DILP (Brogiolo et al., 2001); and 
37 insulin-like ligands, INS in Cenorhabditis elegance (Pierce et al., 2001). They exhibit a 
broad functional diversity and a high degree of structural conservation (Fig. 2) 
 
 
 
Fig. 2 Schematic representation of gene products of the insulin family in vertebrates. The peptide 
domains are presented in relative scale (Lu et al., 2005). 
 
Mammalian IGF-I is a 70 amino acid peptide, with a molecular mass of about 7.5 kDa, 
structurally related to proinsulin (Fig. 3). IGF-I shares with insulin the A and B domains that 
are linked by two disulphide bonds. Like proinsulin, the A and B domains of the IGFs are 
connected through a C domain, but the C domain of IGF-I is considerably shorter than the C 
peptide of proinsulin and exhibits a different sequence. Furthermore, in contrast to insulin, the 
C domains of the IGFs are not proteolytically removed during prohormone processing and, 
therefore, the mature IGF molecules are single-chain polypeptides. In further contrast to 
insulin, the mature IGFs contain additional six to eight-residue carboxy-terminal D domains. 
Finally, the prohormones of the IGFs show further carboxy-terminal extensions, the E 
peptides, which are gradually cleaved during translational processing (Reinecke and Collet, 
1998). 
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Fig. 3 Amino acid sequence of human IGF-I (left) and proinsulin (right). Shared amino acids are 
highlighted in black (Hadley, 1996; Greenspan and Strewler, 1997). 
 
Crystallographic studies revealed the structure of IGF-I as similar to insulin, but also 
substantial dissimilarities resulting from of C chain-derived C-loop on IGF-I were found 
(Brzozowski et al., 2002) (Fig. 4). 
 
 
 
Fig. 4 Superimposed 3-dimensional structure of the human IGF-I and insulin molecules. Insulin is 
represented by blue - A chain and yellow - B chain. IGF-I is represented mostly by green, with brown 
- C domain and purple - D domain (Brzozowski et al., 2002). 
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Fish 
Strong evidence for the presence of IGF-like activity in fish serum was demonstrated already 
in the late seventies (Shapiro and Pimstone, 1977; Komourdjian and Idler, 1978). The first 
fish IGF-I sequence was established for Coho salmon (Cao et al., 1989). Since then, full 
length as well as partial sequences of IGF-I have been deduced in many fish species 
(comprehensive list in: (Wood et al., 2005)), including the tilapia species: Oreochromis 
mosambicus (Reinecke et al., 1997) and Oreochromis niloticus (Cruz et al., 2006). Sequence 
comparison for various classes of vertebrates revealed that the IGF-I sequence is highly 
conserved throughout evolution. Mature teleost IGF-I consists of 68-70 amino acids 
depending on the species and shows an overall 72-81 % sequence similarity with human IGF-
I. Not only sequence, but also biological actions of IGF-I have been shown to be highly 
conserved between the different classes of vertebrates. Numerous studies indicate a high 
potency of human IGF-I to induce 35S incorporation in cartilage of various teleost species. 
Similarly, activities of fish and mammalian IGF-I are almost equally potent in tissues of 
mammals (Duan, 1998). 
 The structure of the fish IGF-I genes tends to be much more compact and simple as 
compared to mammals. In contrast to the human IGF-I gene, which contains six exons and 
spans 100 kilobases (kb), the single fish IGF-I gene is composed of five exons and spans 
around 20 kb (Wood et al., 2005). Multiple mRNA transcripts have been identified in 
numerous teleost species including tilapia (Reinecke et al., 1997). 
 
 
IGF-I Receptor 
 
General 
The receptor for IGF-I (IGF-1R) represents a tyrosine kinase-linked transmembrane receptor. 
The IGF-1R is synthesized as a single peptide of 1367-amino acid sequence and 
proteolytically cleaved into α and β subunits linked by disulfide bonds. Two α chains are 
joined by secondary disulfide bonds to form the mature (αβ)2−receptor. The α subunits are 
extracellular and contain a cysteine-rich domain. The β subunit has a short extracellular 
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domain, a hydrophobic transmembrane domain, and an intracellular tyrosine kinase domain 
and ATP-binding site (Fig. 5). 
 
 
 
Fig. 5 Schematic representation of receptors for insulin, IGF-I and IGF-I/insulin hybrid receptors 
(Jones and Clemmons, 1995). 
 
Despite its name the IGF-1R binds both IGF-I and IGF-II with high affinity, and both IGF 
peptides appear capable of activating tyrosine kinase by binding to the receptor. Insulin can 
also bind to the IGF-1R but with 100- to 1000-fold less affinity, which explains the relatively 
weak mitogenic effects of insulin (Williams and Larsen, 2002). In addition, the IGF receptor 
αβ-pair can form heterodimers with the insulin receptor αβ-pair, IGF-1R (Fig. 5). These 
hybrids only bind IGF-I, which points to the importance of cysteine rich regions as necessary 
for IGF-I binding. 
Upon activation by ligand binding, tyrosine kinase of one β-subunit phosphorylates 
residues on the reciprocal β-subunit. Autophosphorylation of the receptor results in 
recruitment of multiple adaptor and docking proteins, such as the members of insulin receptor 
substrate family (IRS-1 through IRS-4). Recruitment of IRS and other substrates initiates a 
cascade of further phosphorylation events, involving multiple second-messengers. For 
example, recruitment of SH2 domain-containing proteins can activate the monomeric G 
protein Ras, triggering the activation of the mitogen-activated protein kinase (MAPK) 
signaling pathway. The alternative pathway involves the activation of phosphatidylinositol-3 
kinase (PI3-kinase) or protein kinase B (PKB/Akt) signal transduction. The different 
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pathways ultimately influence nuclear transcription and gene expression. These, depending on 
the cell type and cellular context involved, can lead to mitogenic activity, cell proliferation, 
prevention of apoptosis and glucose uptake (Fig. 6) (Wood et al., 2005).  
 
 
 
Fig. 6 Signal transduction cascades emanating from activation of the IGF-I receptor (Le Roith et al., 
2001) 
 
Fish 
The primary structure of the IGF-1R is known for a number of fish species. There is a great 
deal of sequence similarity between mammalian and fish IGF-1R, with the cysteine rich 
region being the most conserved. Two types of IGF-1R (IGF-1Ra and IGF-1Rb) have been 
described in rainbow trout (Greene and Chen, 1999a), zebrafish (Maures et al., 2002) and 
Japanese flounder (Nakao et al., 2002). Some differences in the expression pattern of the IGF-
1R subtypes have been observed. Knockdown studies showed large degrees of functional 
overlap and additive effects, but also some specific functions of subtypes during the 
embryonic development in zebrafish (Schlueter et al., 2006). 
 Binding studies of mammalian and fish IGF-I demonstrated a high affinity of the fish 
IGF-1R to both ligands and, therefore, functional similarity to the mammalian IGF-1R. 
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IGF-Binding Proteins 
 
General 
The majority of the IGFs present in extracellular fluids are found in a complex with specific, 
high affinity insulin-like growth factor-binding proteins (IGFBPs). There are six distinct 
IGFBPs characterized in mammals, 24-45 kDa proteins, which share around 50 % sequence 
similarity to each other (Rechler, 1993). Structurally all IGFBPs share conserved amino N- 
and carboxy C- terminal domains, and a variable central L-domain (Fig. 7).  
 
 
 
Fig. 7 Structure of IGFBP (IGFBP5) (Duan and Xu, 2005). 
 
The N-domain serves as binding site for the IGFs and has 12 conserved cysteine residues. The 
C-domain has the capability of binding other molecules, such as ASL for IGFBP-3 and 
IGFBP-5. The central, linker domain represents the site for post-translational modification 
(Duan and Xu, 2005). 
The functions of the IGFBPs can be divided in three categories. They serve as carriers for the 
IGFs and modulators of IGF action and seem to exert IGF-independent bioactivity (Williams 
and Larsen, 2002). 
 Carrier: In the normal adult serum 75-80 % of all IGF peptides circulate in a 150 kDa 
ternary complex consisting of one molecule of IGF, one molecule of IGFBP-3 and one 
molecule of 88 kDa protein termed the acid-labile subunit (ASL) (Baxter and Martin, 1989; 
Leong et al., 1992). A ternary structure with IGFBP-5 instead of IGFBP-3 is also present, 
however, at much less extent (Twigg et al., 1998; Baxter et al., 2002). Because the large 
molecular mass IGF complex cannot cross the vascular endothelial barrier and is protected 
from proteolytic degradation it acts as a reservoir of IGFs in the serum. Thereby it extends 
half-life of IGF peptide from approximately 10 minutes for IGF alone to 1-2 hours in the IGF-
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IGFBP-3 binary complex to 12-15 hours for IGF in the ternary complex (Guler et al., 1989; 
Zapf, 1995). 
 Modulator: The binding affinity of the IGF peptides to the IGFBPs is higher than that 
to the IGF receptors, which implies that the IGFBPs can modulate IGF-binding to its 
receptors, thereby modulating IGF biological action (Oh et al., 1993; Jones and Clemmons, 
1995; Firth and Baxter, 2002). IGFBPs have been shown to inhibit various actions of IGF-I 
on cell cultures (Okajima et al., 1993; Williams and Larsen, 2002). IGFBP proteases have 
been identified and postulated to play a role in altering IGF availability by lowering the 
affinities of the IGFBPs for their ligand, thereby mobilizing IGFs from the circulating 
reservoir and facilitating the precise delivery of the ligand to the cell membrane receptors 
(Lamson et al., 1993; Cohen et al., 1994; Lee and Rechler, 1995; Lee and Rechler, 1996). 
IGFBPs also are thought to prevent the insulin-like activity of  the IGFs (Mohan and Baylink, 
2002). 
 Independent: Intriguingly, an additional level of complexity in IGFBP function seems 
to emerge: IGF-independent biological actions have now been documented for selected 
members of the IGFBP family. That includes effects on cell migration, cell growth and 
apoptosis. Elucidating the IGF-independent functions of IGFBPs is currently the focus of 
considerable research interest (Duan, 2002; Kelley et al., 2002; Lee and Cohen, 2002; Mohan 
and Baylink, 2002). 
 
Fish 
One or more types of IGFBPs have been identified in blood and tissues of several fish species 
(Kelley, 2006). Binding capability to IGF-I and IGF-II but not to insulin has been 
demonstrated for some of them (Duan et al., 1999; Bauchat et al., 2001; Shimizu et al., 2003). 
The most abundant type of fish IGFBP in serum of tested species is an around 41 kDa 
molecule, which is regulated by GH and considered as the likely homolog to mammalian 
IGFBP-3 (Shimizu et al., 2003). Despite considerable advances in recent years, data regarding 
the function and functional and structural relationship of fish IGFBPs to their mammalian 
orthologs is not conclusive to date (Reinecke et al., 2005).  
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IGF Function in Fish 
 
Growth 
The original phenomenon which demonstrated the growth-promoting function of IGF-I was 
the ability to stimulate 35S incorporation in growing cartilage. This ability of the IGFs was 
demonstrated in numerous teleost species (Wood et al., 2005). Besides sulphation, IGF-I has 
been implicated in many growth-related processes in fish. It stimulates DNA synthesis as 
demonstrated by [3H]thymidine incorporation into cartilage (Duan and Hirano, 1992), gonads 
(Loir and Le Gac, 1994; Srivastava and Vanderkraak, 1994), muscles (Castillo et al., 2004) 
and embryonic cells (Pozios et al., 2001). IGF-I stimulates protein synthesis (Negatu and 
Meier, 1995; Degger et al., 2000; Gallardo et al., 2001). Mitogenic effects of IGF-I were 
shown by the induction of proliferation of retinal cells in cichlids and goldfish (Mack and 
Fernald, 1993; Otteson et al., 2002). Somatic growth was reported after IGF-I infusion in 
salmonids (McCormick et al., 1992). 
 Additional data for the role of IGF-I and the GH−IGF-I axis in teleost growth have 
been obtained from studies of stunted fish, which show retarded growth after abrupt fresh- to 
saltwater transfer (Clarke et al., 1977). GH resistance and IGF-I deficiency have been 
demonstrated in stunted fish (Bolton et al., 1987; Gray et al., 1992; Duan et al., 1995), linking 
GH−IGF-I axis with the regulation of growth in fish. Stunted fish are thought to suffer from 
malnutrition caused by impaired nutrient uptake from food (Collie and Stevens, 1985). 
Indeed, there is also a correlation between nutritional status, GH treatment, IGF-I levels and 
body size or growth rate in fish (Reinecke, 2006). As in other vertebrates, in teleost fish 
starvation causes increase in circulating GH, but reduced GH sensitivity in liver (Gray et al., 
1992; Small et al., 2006). This phenomenon is associated with decreased IGF-I levels in fish 
serum (Moriyama et al., 1994; Small and Peterson, 2005). Conversely, increased food rations 
or high temperature and the resulting increased growth rate correlate with elevated IGF-I and 
decreased GH levels in blood (Perez-Sanchez et al., 1995; Cruz et al., 2006). 
 
Development 
In 1992, Duguay and colleagues showed IGF-I mRNA transcripts in whole embryo of 
salmonids, six weeks post fertilisation, indicating that IGF-I is present during fish 
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embryogenesis and development (Duguay et al., 1992). Since then, IGF-I mRNA and peptide, 
as well as IGF-I receptor have been detected in embryos and larvae of various stages in a 
number of fish species, indicating a functional role for IGF-I in fish development (Reinecke, 
2006). 
 Recent IGF-1R knockdown studies in fish confirm the importance of the IGF-
signaling system during embryonic development. Inactivation of either of two types of IGF-
1R results in delayed development for zebrafish embryo, abnormal morphogenesis and 
dysfunction of several organs, and it is 100 % lethal after 96 hours post fertilization (Schlueter 
et al., 2006). The knockdown of zebrafish IGF-1R alters the expression pattern of genes 
responsible for embryonic development of central nervous system and organization of body 
plan, which causes reduced body size and loss of anterior structures (Eivers et al., 2004). 
 
Osmoregulation 
Osmoregulation represents a considerable challenge for euryhaline or diadromous fishes, 
adapted to strong variation of water salinity (McCormick, 2001). They need to modify or even 
reverse salt balance depending on the environment. Several hormones are thought to direct 
these osmoregulatory processes in fish. While prolactin is considered as the “freshwater 
hormone” that induces freshwater adaptability, cortisol is important during the seawater 
acclimation (Utida et al., 1972). There are strong data that suggest the involvement of the 
GH−IGF-I axis in induction of seawater tolerance in fish (reviewed in: McCormick, 2001; 
Sakamoto and McCormick, 2006). Seawater challenge elevates GH and IGF-I levels (Lindahl 
et al., 1985; Sakamoto and Hirano, 1993; Yada et al., 1994), whereas administration of IGF-I 
enhances the ability to maintain plasma osmolality (Clarke et al., 1977; McCormick et al., 
1991; Madsen et al., 1995; McCormick, 1996) and improves the tolerance to water salinity 
(Mancera and McCormick, 1998). The mechanisms responsible for these osmoregulatory 
activities involve the stimulation of Na+,K+-ATPase activity in chloride cells and the increase 
of their numbers in gills (Madsen and Bern, 1993; McCormick et al., 1995; Xu et al., 1997; 
Seidelin et al., 1999), which improves the salt-secretory capacity of gills and facilitates water 
retention from urinary bladder, gut and kidney (Utida et al., 1972). Changes in GH and IGF-I 
plasma levels, along with increase of prolactin levels, have also been observed after 
freshwater transfer in tilapia (Riley et al., 2003). 
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 IGF-I along with GH, insulin and thyroxine have been all implicated in parr-smolt 
transformation in juvenile salmonids. This process represents metamorphic modifications 
associated with freshwater to salt water transfer during migration of anadromous fish species 
to the sea. During this process elevated IGF-I levels were found in liver (Duan et al., 1995), 
additionally in gills (Duguay et al., 1994), and in gills and kidney (Sakamoto and Hirano, 
1993), but not in brain, muscle or ovary (Duguay et al., 1994; Duan et al., 1995).  
 
Reproduction 
The IGF system is strongly involved in reproductional processes in fish. The IGFs and the 
IGF-1R have been found in testes and ovaries of many teleost species. In females peptides 
have been localised in the cytoplasm of young oocytes, granulosa cells and steroid-producing 
theca cells of fish ovary (Schmid et al., 1999; Perrot et al., 2000). In the testes, IGF-I has been 
found in Sertoli cells, spermatocytes and Leydig cells (LeGac et al., 1996; Reinecke et al., 
1997; Perrot et al., 1999). In the ovary IGF-I stimulates oocyte maturation (Kagawa et al., 
1994; Negatu et al., 1998) and thickening of gap junctions in the granulosa layer (Patino and 
Kagawa, 1999). In males, IGF-I stimulates spermatogenesis (Loir and Le Gac, 1994; Loir, 
1999) and enhances spermatogenic action of testosterone (Nader et al., 1999). 
 Another aspect of IGF-I action with respect to reproduction is its ability to influence 
the secretion of reproductive hormones. It has been shown that IGF-I inhibits testosterone 
production, whereas it stimulates the synthesis of estradiol, progesterone (Maestro et al., 
1997) and maturation-inducing steroid (MIS) (Weber and Sullivan, 2000). IGF-I also 
stimulates the release of gonadotropins from the pituitary, such as luteinizing hormone (LH) 
(Huang et al., 1998), and enhances pituitary response to the activities of hypothalamic 
gonadotropin releasing hormones (Weil et al., 1999; Baker et al., 2000). 
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Tilapia model system 
 
The Nile tilapia, Oreochromis niloticus (Fig. 8) belongs to the tentative Tribe Tilapiini, 
represented by the three main genera, Tilapia, Sarotherodon and Oreochromis (Trewavas, 
1983). Tilapiini along with Haplochromini represent two major groups in the Family 
Cichlidae (Regan, 1920). The Family Cichlidae is classified in the Order Perciformes, the 
largest order of vertebrates, with more then 9200 species (Moyle and Cech, 2004). 
 
 
 
Fig. 8 Nile tilapia, Oreochromis niloticus 90 DPF. 
 
The Nile tilapia is a tropical, freshwater fish which occupies a wide variety of freshwater 
habitats such as rivers, lakes, sewage canals and irrigation channels (Bailey, 1994). It is also 
found in the brackish water of river deltas and estuaries. Tilapia is omnivorous and feeds on 
phytoplankton, aquatic plants, small invertebrates, benthic fauna, detritus, etc. 
 It is naturally distributed in Africa: coastal rivers of Israel, Nile from below Albert 
Nile to the delta, Jebel Marra, Lake Chad basin and the rivers Niger, Benue, Volta, Gambia 
and Senegal [www.fishbase.org]. The Nile tilapia has been introduced worldwide for 
aquaculture and as a result, can be found in various sites outside its area of natural 
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distribution, not only in Africa, but all around the world. Several countries report adverse 
ecological impact after introduction. 
 The tilapia is an important commercial fish. It has been cultured already in ancient 
Egypt, as indicated by its frequent occurrence in ancient Egyptian art, dating back for over 
4000 years. From the middle of 20th century, tilapia aquaculture started spreading worldwide 
and currently is performed in more than 75 countries in Africa, Asia and the Americas, with 
China as the biggest producer. Thus, the tilapia is a substantial aquaculture fish, reaching 
worldwide production of 1.5 million tones in 2004 (FAO, 2005), which makes it one of the 
most cultured fish along with carp and salmon.  
 
 
 
Fig. 9 Tilapia amulet form the Tomb of Mena, First Dynasty of ancient Egypt. 
 
 Male Nile tilapias are polygynous, they build and defend spawning pits where they  
mate with a number of females. All Oreochromis species are maternal mouthbrooders. After 
fertilization, the females pick the eggs and incubate them in their buccal cavity. Subsequently, 
yolk-sac fry stays in the mouth of the mother until the start of external feeding. At this time, 
fry is guarded by the mother and in case of danger sheltered in the mouth (Beveridge, 2000). 
Females can spawn 4-6 times per year and a single female produces 1-2 eggs per gram of 
body.  
 Cichlids have been studied for a long time especially for their remarkable evolutionary 
radiation and diversity of Haplochromini flocks in the Great Lakes of Africa. As the 
commercial value for tilapia cichlids increased, they have been extensively investigated in the 
field of endocrinology, molecular genetics and reproduction. Oreochromis niloticus proved to 
be very suitable model species for biological studies with many advantages. The fish are easy 
to rear in the aquarium. They can be bred year-round with a short generation period (they 
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reach sexual maturity in five to six months). They have large eggs, embryos and larva, which 
makes them useful for various observations. Adult fish are also large and therefore suitable 
for diverse physiological studies. At present, almost 6000 entries for tilapia can be found 
throughout nucleotide database at NCBI, sequencing of the tilapia genome is underway by 
The Cichlid Genome Consortium (http://hcgs.unh.edu/cichlid/). There are successful 
transgenic technologies applied for Nile tilapia (Rahman and Maclean, 1992; Pohajdak et al., 
2004). 
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 Aims of the study 
 
Similarly to mammals, after birth liver becomes the major source for circulating IGF-I in fish 
(Reinecke and Collet, 1998). However, the actions of IGF-I in different non-hepatic tissues 
are thought to be complemented by locally produced IGF-I, that acts in autocrine or paracrine 
fashion. In adult teleost fish, IGF-I is produced in numerous organs such as: central nervous 
system, gills, muscles, gastro-intestinal tract, kidney, heart and gonads (Reinecke et al., 1997; 
Perrot et al., 1999; Maures et al., 2002; Vong et al., 2003). Also in the tilapia, in addition to 
liver, IGF-I mRNA transcripts have also been reported to occur in various extra-hepatic sites 
(Caelers et al., 2004). The local action of IGF-I may even be more important during early 
development. The expression of IGF-I during fish ontogeny has been reported, mainly 
focusing on IGF-I content in the whole fish body (Greene and Chen, 1999b; Perrot et al., 
1999; Ayson et al., 2002; Maures et al., 2002; Deane et al., 2003; Gabillard et al., 2003), 
whereas the tissue distribution of IGF-I and its cellular localization during fish ontogeny has 
been described so far only in few reports (Berwert et al., 1995; Perrot et al., 1999; Radaelli et 
al., 2003).  
 This study investigates the presence of IGF-I during early ontogeny of tilapia, during 
the processes of organogenesis, somatic growth and sexual differentiation. The aim is to 
understand the possible pathways of IGF-I action looking at the endocrine, liver-derived 
route, as well as at local non-hepatic IGF-I. For this purpose, a morphological approach, using 
the correlation of immunohistochemistry and in situ hybridization techniques is employed to 
reveal the cellular localization of IGF-I peptide and mRNA, respectively. The study is carried 
out on monosex fry of Nile tilapia, Oreochromis niloticus, during its development and in adult 
life. 
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Chapter 1 
 
 
Organ-specific expression of IGF-I during early development of bony fish as 
revealed in the tilapia, Oreochromis niloticus, by in situ hybridization and 
immunohistochemistry: indication for the particular importance of local IGF-I* 
 
The cellular sites of insulin-like growth factor I (IGF-I) synthesis in the early developing 
tilapia (0-140 days post fertilization, DPF) were investigated. IGF-I mRNA and peptide 
appeared in liver as early as 4 DPF and in gastro-intestinal epithelial cells between 5-9 DPF. 
In exocrine pancreas, the expression of IGF-I started at 4 DPF and continued until 90 DPF. 
IGF-I production was detected in islets at 6 DPF in non-insulin cells and occurred throughout 
life. In renal tubules and ducts, IGF-I production started at 8 DPF. IGF-I production in 
chondrocytes had its onset at 4 DPF, was more pronounced in growing regions and was also 
found in adults. IGF-I mRNA and peptide appeared in the cytoplasm of skeletal muscle cells 
at 4 DPF. In gill chloride cells, IGF-I production started at 6 DPF. At 13 DPF, IGF-I was 
detected in cardiac myocytes. IGF-I-producing epidermal cells appeared at 5 DPF. In brain 
and ganglia, IGF-I was expressed in virtually all neurones from 6 to 29 DPF, their number 
decreasing with age. Neurosecretory IGF-I-immunoreactive axons were first seen in the 
neurohypophysis around 17 DPF. Endocrine cells of the adenohypophysis exhibited IGF-I 
mRNA at 28 DPF and IGF-I immunoreactivity at 40 DPF. Thus, IGF-I appeared early (4-5 
DPF), first in liver, the main source of endocrine IGF-I, and then in organs involved in growth 
or metabolism. The expression of IGF-I was more pronounced during development than in 
juvenile and adult life. Local IGF-I therefore seems to have a high functional impact in early 
growth, metabolism and organogenesis. 
 
 
 
_________________________ 
* Berishvili G, Shved N, Eppler E, Clota F, Baroiller JF, Reinecke M, Cell Tissue Res. 2006 Apr 5 
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Introduction 
 
Autocrine, paracrine and endocrine signals co-ordinate the direction of differentiation of 
tissues during critical periods of development. The differentiation of organs thus involves a 
complex cascade and interaction of signals whose organisational action on tissue 
differentiation is dependent on being released at precise times, at correct sites (in the case of 
para- and autocrine factors) and within a specific dose range (Segner at al. 1994). Insulin-like 
growth factor I (IGF-I) plays a central role in the complex system that regulates growth, 
differentiation, and reproduction (see review: Reinecke and Collet 1998). 
 Like in mammals, the major site of IGF-I gene expression in bony fish is liver but 
several extrahepatic sites also express IGF-I (see reviews: Reinecke and Collet 1998, Duan 
1998¸ Reinecke et al. 2005; Wood et al. 2005). Recently, by the use of real-time reverse 
transcription/polymerase chain reaction (RT-PCR), the absolute amounts of IGF-I were 
measured in adult tilapia, Oreochromis niloticus (Caelers et al. 2004), and significant levels of 
IGF-I mRNA were measured not only in liver but also in other organs, such as brain, gills, 
heart, intestine, kidney, skeletal muscle, spleen and testes. These results are consistent with 
the earlier immunohistochemical identification of parenchymal cells as local production sites 
in numerous organs of tilapia (Reinecke et al. 1997) and indicate paracrine/autocrine actions 
of local IGF-I involved in organ-specific functions of adult bony fish.   
 Some studies in bony fish showing the presence of IGF-I and its receptor (IGF-1R) in 
fish embryos suggest a high organisational impact of IGF-I during ontogeny. Developmental 
and tissue specific regulation of the steady-state mRNA levels of the IGF-1R and 
polyadenylation were detected in rainbow trout (Greene and Chen 1999) and seabream (Perrot 
et al. 1999). Correspondingly, some RT-PCR studies on trout (Shamblott and Chen, 1993; 
Duan et al. 1995; Greene and Chen, 1997, 1999), seabream (Duguay et al. 1996; Perrot et al. 
1999) and rabbitfish (Ayson et al. 2002) suggest that the expression patterns of IGF-I mRNA 
in several organs are also age-dependent. The physiological importance of IGF-I in early fish 
development is also stressed by the demonstration of marked mitogenic effects of IGF-I on 
zebrafish embryonic cells (Pozios et al. 2001).  
 However, little information exists regarding the cellular sites of IGF-I synthesis, with 
only two studies in seabream (Perrot et al. 1999) and rabbitfish (Radaelli et al. 2003) and 
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some preliminary data in tilapia (Shved et al. 2005) reporting the localisation of IGF-I during 
ontogeny. These reports involve the investigation of several organs at different larval stages 
by the use of immunohistochemistry. However, no thorough study on the cellular IGF-I 
production during early fish development has been performed and no other species have been 
studied. Furthermore, to date, in situ hybridization has not been used to detect the cellular 
expression of  IGF-I mRNA during ontogeny. Therefore, we have investigated the potential 
production sites of IGF-I in numerous organs, such as liver, gastro-intestinal tract, exo- and 
endocrine pancreas, kidney, skeletal muscle,  cartilage, gills, skin, brain and pituitary, in early 
developmental stages, i.e. from 0 day post fertilization (DPF) to 140 DPF, of tilapia 
(Oreochromis niloticus) and in adult individuals. The study uses immunohistochemistry to 
localize the IGF-I  peptide and in situ hybridization for the expression of IGF-I mRNA. 
 
 
Material and methods 
 
Animals 
Fry and adult Oreochromis niloticus used in this study originated from the Aquaculture 
Experimental facilities of CIRAD (Montpellier). Fertilized eggs were either obtained through 
natural or artificial fertilizations. For natural fertilizations, 0. niloticus breeders (1 male and 3 
females) were maintained in a spawning aquarium of 360 l maintained at constant temperature 
(27°C) and photoperiod (12L:12D). Under natural photoperiods, reproductive activity 
occurred mainly from the afternoon until sunset in this species (Baroiller et al. 1997). 
Consequently, we checked every morning for the presence of newly incubating females, 
which were then isolated from the other fish. On the first day after fertilization, eggs were 
gently removed from the mouth of the female, and incubated in 1-l McDonald jars at 27 ± 1 
°C (mean range). For artificial fertilizations, maturation of isolated females was carefully 
recorded (i.e. uro-genital papilla development and behavior). When nearly breeding stage was 
reached, both male and female breeders were striped under anesthesia. Fertilizations were 
performed according to Chourrout and Itskovitch (1983). After fertilization, eggs were 
incubated in 1-l McDonald jars, maintained at 27°C, to the free-swimming stage (around 10 
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DPF). Just before the completion of  yolk sac absorption, fry were placed into a 50-l tank in 
an indoor recirculating system at 27±1°C. They were fed with commercial salmonid food. 
Fish larvae at different developmental stages, i. e.  from 0-140 DPF, and adults were 
sampled and anaesthetized by the addition of 2-phenoxy-ethanol (Sigma, St. Louis, MO, 
USA) to water (0.3 ml/l). For the earliest stages, trunk was cut to allow fixation solution to 
enter. If the larvae had reached a sufficient size, the organs were excised. Tissue preparations 
were fixed with Bouin’s solution without acetic acid for 4 h at room temperature. Specimens 
were dehydrated in an ascending series of ethanol and routinely embedded in paraplast 
(58°C). 
 
Generation of tilapia-specific probes for in situ hybridization 
Probes used were prepared as already described (Schmid et al. 1999). In brief, total RNA 
from tilapia liver was extracted by the phenol/chloroform method with the Ultraspec 
Extraction Kit (ams, Lugano, Switzerland). For cDNA synthesis, 5 µg RNA were annealed 
with 1 µM of a poly(dT) primer (5' CCT GAA TTC TAG AGC TCA T(dT17) 3') for 3 min at 
70°C. The RNA/primer mix was incubated for 1 h at 37°C with 15 mM dNTPs and 10 U 
AMV-reverse transcriptase (Pharmacia, Switzerland) in 1x reaction buffer (50 mM TRIS-HCl 
pH 8.3, 40 mM KCl, 6 mM MgCl2). A 1-µl cDNA aliquot was incubated with 1 µM of the 
sense (5`-GTC TGT GGA GAG CGA GGC TTT-3`) and antisense primer (5’-AAC CTT 
GGG TGC TCT TGG CAT G-3`), corresponding to the B- and E- domains (Reinecke et 
al. 1997), 200 µM dNTPs, and 1 U Taq-polymerase (Pharmacia) in 1x incubation buffer (10 
mM TRIS-HCl pH 8, 50 mM KCl, 1.5 mM MgCl2, 0.001 % gelatine). The amplification 
program was optimized for a Stratagene RoboCycler Gradient 40 as follows: one cycle of 10 
min at 94°C, 1 min at 59°C, 2 min at 72°C; 30 cycles of 1 min at 94°C, 1 min at 59°C and 2 
min at 72°C followed by a final extension step of 5 min at 72°C. PCR fragments were 
separated on a 2 % agarose gel and eluted by the Gel Extraction Kit QIAquick (Qiagen, 
Switzerland). PCR products were cloned in a pCR-Script SK(+) cloning vector (Stratagene, 
Heidelberg, Germany). After propagation of Escherichia coli containing the plasmids, 
purification of the plasmids was performed with the Midi Purification Kit (Qiagen). Plasmids 
with the IGF-I fragment were sequenced (Microsynth, Switzerland) and the sequences were 
compared with those in a database. The plasmids containing the specific inserts of IGF-I (207 
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bp), were used as templates for the synthesis of the digoxigenin (DIG)-labelled RNA probes. 
Linearization was performed with the restriction enzyme EcoRI for T3 polymerase-driven 
transcription and with NotI for T7 polymerase-driven transcription. After ethanol 
precipitation, linearization efficiency was assured on a 1.2% agarose gel. The linearized 
plasmids (1 µg) were transcribed in vitro by using a transcription kit (Roche Diagnostics, 
Germany) in the presence of DIG-UTP to obtain the antisense and sense probes. The IGF-I 
probes selectively detected tilapia IGF-I and not tilapia IGF-II, as shown previously (Schmid 
et al. 1999). Integrity of probes and efficiency of labelling were confirmed by gel 
electrophoresis, including blotting and incubation with antibody (Ab), and by dot blot. For dot 
blot, 1 µl of different dilutions (undiluted, 1:10, 1:100, 1:1000) of probes and control RNAs 
were dropped on a nylon membrane (Roche-Diagnostics) and fixed by UV cross-linking (254 
nm, 125 mJ). The membrane was washed with 1% blocking reagent (Roche-Diagnostics) in 
buffer P1 for 30 min. After a rinse with P1 the membrane was equilibrated with buffer P3 and 
finally washed with 1:50 diluted nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate 
(NBT/BCIP) stock solution (Roche-Diagnostics) until colour development. For gel 
electrophoresis and blotting probes (200 ng) were loaded on a 1% denaturing formaldehyde 
agarose gel in 1x MOPS and run at 80 V for 1.5 h. After the run, the gel and the membrane 
were shaken in diethylpyrocarbonate (DEPC)-H20 for 5 min. Capillary transfer was carried 
out with 20x standard sodium citrate (SSC) overnight. Nucleic acids were fixed by UV-
crosslinking. Subsequently, the membrane was incubated with AP-labelled anti-DIG Ab by 
applying the same procedure as for dot blot. Lengths of the probes were compared with a 
control RNA (760 nt, Roche Diagnostics).  
 
In situ hybridization protocol 
Sections (4 μm thick) were mounted on Super Frost Plus slides (Menzel-Gläser, Germany) 
and dried overnight at 42°C. After being dewaxed and rehydrated, the sections were fixed 
with 4% paraformaldehyde and 0.1% glutaraldehyde in 1x phosphate-buffered saline (PBS). 
The following steps were carried out with DEPC-treated solutions in a humified chamber. The 
sections were digested with 0.02% proteinase K in 20 mM TRIS-HCl pH 7.4, 2 mM CaCl2 for 
10 min at 37°, treated with 1.5 % triethanolamine and 0.25% acetic anhydride for 10 min at 
room temperature and incubated with 50 µl prehybridization solution per section for 3-4 h at 
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54°C. Hybridization was carried out overnight at 54°C with 30 µl of hybridization buffer 
containing 10 ng of sense or antisense probe previously denaturated for 5 min at 85°C. Slides 
were washed for 15 min at room temperature in 2x SSC, and for 30 min at the specific 
hybridization temperature at descending concentrations of SSC (2x, 1x, 0,5x, 0,2x). The anti-
DIG AP-coupled Ab was diluted 1:4000 in 1% blocking reagent (Roche-Diagnostics) in 
buffer P1 and applied to the sections for 1 h at room temperature in the dark. After being 
washed twice in P1 for 15 min, the sections were treated with buffer P3, 5 mM levamisole and 
NBT/BCIP stock solution (Roche Diagnostics). Colour development was carried out 
overnight at room temperature and stopped by rinsing in tap water for 15 min. 
 
Immunohistochemistry  
Sections were cut at 4 µm, mounted onto glass slides (Menzel-Gläser) and dried overnight at 
42°C. After being dewaxed and rehydrated, they were used for immunohistochemistry. To 
reduce unspecific binding, sections were treated with PBS (pH 7.4) containing 2% bovine 
serum albumine for 30 min at room temperature. Thereafter, the sections were incubated 
overnight with the rabbit antiserum 116 raised against human IGF-I (Reinecke et al. 1997; 
Schmid et al. 1999) diluted at 1:400 and washed repetitively in PBS. The IGF-I antiserum was 
detected by incubation with biotinylated goat anti-rabbit IgG (Bioscience Products, 
Emmenbrücke, Switzerland, 1:100) for 30 min at room temperature. After repetitive rinses in 
PBS, the sections were incubated with streptavidin-fluorescein-isothiocyanate (Bioscience 
Products, 1:100) for 30 min at room temperature in the dark. Specificity of the reactions 
obtained was tested using the following controls: (1) replacement of the primary antiserum by 
non-immune rabbit serum, (2) pre-absorption of the primary antiserum with recombinant 
human (h) IGF-I, hIGF-II, porcine insulin (kind gift of Prof. J. Zapf, Zürich) or the peptide 
used for immunization (40 µg or 400 µg peptide/ml diluted antiserum). Photomicroscopy was 
performed with a Zeiss Axioscope using the Axiovision software 3.1. (Zeiss, Zürich, 
Switzerland). 
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Results 
 
General 
During early development, IGF-I mRNA and peptide were observed in all organs 
investigated. However, the onset of IGF-I expression and its duration differed considerably 
among the different tissues and organs (Table 1). 
 
Liver 
At 4 DPF, several hepatocytes started to exbibit IGF-I mRNA followed by IGF-I 
immunoreactivity around 6-7 DPF (Table 1). By 12 DPF, numerous hepatocytes showed IGF-
I mRNA and some also contained IGF-I peptide (Fig. 1a,b). Around 36 DPF, a larger number 
of hepatocytes contained IGF-I mRNA (Fig. 1d) and about half of the hepatocytes also 
possessed IGF-I immunoreactivity at variable intensity (Fig. 1c). Whereas the expression of 
IGF-I mRNA persisted in hepatocytes, the presence of IGF-I peptide decreased with age and 
could not be detected after 90 DPF. 
 
Gastro-intestinal tract 
IGF-I mRNA and peptide appeared in cells of the intestinal mucosal epithelium at 5 DPF 
(Fig. 2 a, b). At 9 DPF, they were also detected in cells of the stomach epithelium. Virtually 
all epithelial cells of the gastro-intestinal tract contained IGF-I mRNA and peptide. IGF-I 
immunoreactive material was mainly located in the cell apex (Figs. 2a,c,d). The largest 
numbers of mucosal epithelial cells exhibiting IGF-I mRNA and peptide were found at 13-29 
DPF (Fig. 2c-e, Table 1). Around 17 DPF, additional IGF-I containing cells were detected 
with the typical appearance of endocrine cells (Fig. 2c). These IGF-I immunoreactive cells 
occurred in all portions of the gastro-intestinal tract but their distribution and frequency varied 
largely among different individuals. The cells persisted until the adult stage, whereas the 
presence of IGF-I immunoreactivity in the cell apex was limited to about 50 DPF (Table 1). 
 
Pancreas 
In the exocrine pancreas, the first cells with IGF-I mRNA were present already at 4 DPF. 
Their number increased at around 6 DPF (Fig. 2f) and persisted at a high level until 18 DPF 
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(Table 1). Thereafter, the number of IGF-I containing acinar cells decreased until about 90 
DPF and could not be detected in adults. 
At 6 DPF, some islet cells containing IGF-I mRNA (Fig. 2f) and peptide. Their 
number increased until 18 DPF. The IGF-I containing islets cells did not contain insulin (Fig. 
2g,h).  
 
Kidney 
At 8 DPF, IGF-I-immunoreactivity (Fig.  3a) and mRNA appeared in the vast majority of 
renal vesicles and in the pronephric ducts. Faint IGF-I  immunoreactivity (Fig. 3b) and 
mRNA were present in the renal tubules forming around 13 DPF. In the pronephric ducts, 
IGF-I immunoreactivity was located in the apical cell portion (Fig. 3a,b). Around 17 DPF, the 
epithelial cells of the pronephric urinary ducts (Fig. 3c) contained strong IGF-I 
immunoreactivity in the cell apex. Furthermore, numerous proximal tubules exhibited IGF-I 
mRNA (Fig. 3d) and immunoreactivity (Fig. 3e), whearas most of the distal tubules showed 
only faint reactions (Fig. 3e). This distribution pattern persisted until 25 DPF (Fig. 3f). Later, 
some proximal and distal tubules contained IGF-I immunoreactivity (Fig. 3g) and mRNA. In 
addition, strong IGF-immunoreactivity was present in the apical cell portions of the collecting 
ducts (Fig. 3g). The same distribution pattern was also found in juvenile and adult tilapia 
(Table 1). 
 
Cartilage 
Even at 4-5 DPF, IGF-I mRNA and peptide were present in cartilage (Table 1). The 
expression of IGF-I was most pronounced in growing regions (Fig. 4a,b). Numerous 
chondrocytes expressing IGF-I were found in cartilage of various locations (Fig. 4c,d,g, 5a, 
6a,d) throughout development. Their number slowly decreased with time and they were also 
found in adult life.  
IGF-I was detected by in situ hybridisation and immunohistochemistry also in the 
perichondrium starting at 4 DPF. The expression of IGF-I in the perichondrium was most 
pronounced between 6 and 50 DPF (Table 1) and persisted throughout life at a moderate 
level. 
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Muscle 
IGF-I mRNA and peptide appeared in skeletal muscle fibers at 4 DPF (Table 1). Both were 
present in the cytoplasm (Fig. 4 e,f). The highest expression of IGF-I in skeletal muscle was 
between 8 and 29  DPF (Table 1). Thereafter, it decreased (Fig. 4 g) but persisted throughout 
development and adult life. 
 
Gills 
The production of IGF-I in gills had its onset at 6 DPF (Fig. 5a; Table 1). From the beginning 
both IGF-I mRNA and peptide occurred in the majority of chloride cells. This distribution 
pattern was found throughout development (Fig.  5 b,c) and adult life. 
 
Heart 
At 13 DPF, IGF-I was first detected in the developing heart (Table 1). IGF-I was present both 
in atrial (Fig. 5d) and ventricular (Fig. 5e) myocardiocytes. The highest amount of IGF-I-
containing myocardiocytes was present from 19 to 29 DPF. In general, the number of cells 
showing IGF-I mRNA was higher than that of cells exhibiting IGF-I-immunoreactivity (Table 
1). During late development and in adults, no IGF-I could be detected in the heart. 
 
Brain 
In brain, strong IGF-I mRNA signals were revealed in numerous neurones of the brain of 
larvae (Fig. 6a) starting around 6 DPF (Table 1). Similarly, IGF-I immunoreactivity was 
present in the vast majority of neurones (Fig. 6c). In addition, IGF-I was expressed in spinal 
(Fig. 6d) and in developing autonomic ganglia. This overall neuronal presence of IGF-I 
persisted until about 29 DPF and slowly decreased thereafter. In older larvae and adult 
individuals, IGF-I mRNA and peptide, although still found at all levels of brain and spinal 
cord, were present in some neurones only. In the older fish, the number of neurones 
containing IGF-I mRNA exceeded that of the IGF-I-immunoreactive neurones. Whereas in 
most areas of the brain the distribution patterns of IGF-I mRNA and peptide varied largely 
among the individuals investigated, the Purkinje cells in the cerebellum always showed IGF-I 
peptide (Fig. 6e) and mRNA (Fig. 6f). Starting at 4 DPF, IGF-I-immunoreactivity and mRNA 
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were observed in the meninges (Fig. 6a). The expression of IGF-I persisted at the initial level 
until 50 DPF but stayed at a low level throughout life (Table 1). 
 
Pituitary 
IGF-I occurred in both portions of the tilapia pituitary but appeared later than in brain. The 
first neurosecretory axons containing IGF-I-immunoreactivity (Fig. 7a,c) appeared in the 
posterior (neuro-) pituitary around 17 DPF (Table 1). Their density decreased with age but 
they were still detected in adults. No IGF-I mRNA was detected in the posterior pituitary. 
IGF-I-immunoreactive neurons occurred in hypothalamus (Fig. 7c). In endocrine cells of the 
anterior (adeno-) pituitary first exhibited IGF-I mRNA at 28 DPF (Fig. 7b) followed by IGF-I 
immunoreactity at 40 DPF (Fig. 7c). IGF-I-immunoreactivity (Fig. 7c) and mRNA (Fig. 7d) 
in endocrine cells were present throughout development and in adults. 
 
Skin 
At 5 DPF, IGF-I-immunoreactivity appeared in cells of the epidermis (Fig. 8a). First, the 
number of epidermal cells exhibiting IGF peptide (Fig. 8b) and mRNA (Fig. 8c) increased 
with age to reach the highest level around 19-29 DPF (Table 1). In older larvae (Fig. 8d,e) and 
adults some superficial epidermal cells (arrows) and occasionally also cells in the basal 
epidermis (arrowhead) were IGF-I-immunoreactive or contained IGF-I mRNA (Fig. 8e). 
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Table 1 Semiquantitative grading of the number of parenchymal cells demonstrated by IGF-I 
in situ hybridization (ISH) and IGF-I immunohistochemistry (IHC) 
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Fig. 1 IGF-I-immunoreactivity (a, c) and mRNA (b, d) in developing tilapia liver. a, b At 12 
DPF, many hepatocytes exhibit IGF-I-immunoreactivity (a, white arrows) and IGF-I mRNA 
(b, black arrows). Numerous mucosal epithelial calls of the intestine (I) contain IGF-I mRNA 
(b). Bar 20 μm. c, d Tilapia liver at 36 DPF. IGF-I-immunoreactivity of variable intensity (c, 
white arrows) and mRNA (d, black arrows) occur in numerous hepatocytes (V vein). Bar 30 
μm 
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Fig. 2 IGF-I-immunoreactivity and mRNA in developing tilapia gastro-intestinal tract and 
pancreas. a, b At 5 DPF, most mucosal epithelial cells in the developing intestine show IGF-I-
immunoreactivity in the apex (a) and also IGF-I mRNA (b) on consecutive sections. Bar 25 
μm. c At 17 DPF, additional IGF-I containing cells (arrows) are found with the typical 
appearance of endocrine cells. Bar 25 μm. d, e At  29 DPF,  numerous cells in the mucosal 
epithelium of the stomach are IGF-I-immunoreactive (d) and contain IGF-I mRNA (e). Bar 
40 μm. f At 6 DPF, several endocrine cells in the islet contain IGF-I mRNA (arrows). 
Numerous acinar cells of the surrounding exocrine pancreas (ex, arrows) also exhibit IGF-I 
mRNA. Bar 25 μm. g At 76 DPF, no IGF-I-immunoreactivity is observed in the exocrine 
pancreas but numerous cells in the islets are IGF-I-immunoreactive. As shown by double 
immunofluorescence, these cells constitute a subpopulation different from the insulin-
immunoreactive cells (h). Bar 25 μm  
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Fig. 3 IGF-I in developing kidney. a At 8 DPF, IGF-I immunoreactivity is present in most of 
the renal vesicles (rv) and in the pronephric duct (pd). Bar 25 μm. b At 13 DPF, several renal 
tubules (rt) contain faint IGF-I immunoreactivity. In the pronephric duct (pd), IGF-I 
immunoreactivity is located in the apical cell portion (hk head kidney). Bar 30 μm. c-e 17 
DPF. Epithelial cells of the pronephric urinary ducts (pud) show strong IGF-I 
immunoreactivity in the apex at 17 DPF. Numerous proximal (pt) and distal (dt) tubules 
exhibit IGF-I mRNA (d) and immunoreactivity (e). Bars 20 μm (c), 30 μm (d), 20 μm (e). f 
At 25 DPF, most of the proximal tubules (pt) contain IGF-I mRNA but no expression is seen 
in the distal tubules (dt). Bar 20 μm. g At 29 DPF, some proximal (pt) and distal (dt) tubules 
as well as a collecting duct (cd) show IGF-I immunoreactivity. Bar 15 μm. 
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Fig. 4 IGF-I in developing cartilage (a-d) and skeletal muscle (e-g). a At 10 DPF, most 
chondrocytes and the perichondrium (pc) contain IGF-I-immunoreactivity. b The expression 
of IGF-I mRNA is particularly pronounced in growing regions (large arrow) at 17 DPF. IGF-
I mRNA further occurs in the perichondrium (pc). Bar 15 μm (a, b). IGF-I immunoreactivity 
(c) and mRNA (d) are present in the majority of chondrocytes of spine and rib cartilage as 
well as in skeletal muscle (arrows) at 20 DPF. Bar 30 μm. IGF-I-immunoreactivity (e) and 
mRNA (f) are found in the cytoplasm of all sketetal muscle fibers at 17 DPF. Bar 10 μm. g At 
50 DPF, still numerous muscle fiber show IGF-I-immunoreactivity (ca cartilage). Bar 50 μm 
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Fig. 5 IGF-I-immunoreactivity and mRNA in gills (a-c) and heart (d, e). a At 6 DPF, IGF-I-
immunoreactivity is present in numerous of chloride cells and also occurs in gill cartilage 
(ca). Bar 45 μm. b, c The production of IGF-I is found in most chloride cells (arrows) in later 
development as shown for 70 DPF. Bar 20 μm. d, e The presence (arrows) of IGF 
immunoreactivity (d) and mRNA (e) in cardiomyocytes of the developing heart is shown at 
29 DPF. Bar 20 μm 
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Fig. 6 IGF-I in central and peripheral nervous system. a, b In situ hybridisation of serial 
sections of tilapia brain with an IGF-I antisense probe (a) and an IGF-I sense probe (b) at 20 
DPF. Abundant neurons exhibit IGF-I mRNA (a) while no IGF-I mRNA is located in the 
negative control (b). IGF-I mRNA also occurs in the meninges (arrowheads), in chondrocytes 
of the cartilage (ca) and in skeletal muscle cells (arrows, m). Bar 40 μm. c IGF-I-
immunoreactivity is present in numerous central neurones at 20 DPF. Bar 100 μm. d Several 
neurones in the spinal ganglion (SG) exhibit IGF-I-immunoreactivity (ca cartilage). Bar 20 
μm. e, f At 70 DPF, Purkinje cells (arrows) in the cerebellum contain IGF-I peptide (e) and 
IGF-I mRNA (f). Bar 25 μm 
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Fig. 7 IGF-I-immunoreactivity and mRNA in the pituitary as revealed on two pairs of 
consecutive sections (a, b and c, d) processed for immunofluorescence (a, c) and in situ 
hybridisation (b, d). a, b At 28 DPF, numerous axons in the neuropituitary contain IGF-I 
immunoreactivity (a) but no IGF-I mRNA is present (b). In the adenopituitary, most of the 
endocrine cells exhibit IGF-I mRNA (b), whereas they do not show IGF-I-immunoreactivity 
(a). Most neurons of the hypothalamus (H) exhibit IGF-I mRNA (b). Bar 40 μm. c, d At 40 
DPF, both IGF-I immunoreactivity (c) and mRNA (d) are detectable in endocrine cells of the 
anterior pituitary. IGF-I-immunoreactive axons are present in the posterior part. An IGF-I-
immunoreactive neuron (c, arrow) is shown in the hypothalamus. Bar 70 μm 
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Fig. 8 IGF-I-immunoreactivity and mRNA in the skin. a At 5 DPF, several cells in the 
epidermis contain IGF-I-immunoreactivity. In the dermis, a possible dendritic cell also shows 
IGF-I-immunoreactivity (arrow). Bar 40 μm. b, c At 25 DPF, numerous cells in all epidermal 
layers exhibit IGF-I peptide (b) and mRNA (c). Bar 30 μm. d, e Frequent superficial 
epidermal cells (arrows) and infrequent basal epidermal cells (arrowheads) exhibit IGF-I 
immunoreactivity (d) and mRNA (e) at 36 DPF. Bars 50 μm (d), 40 μm (e) 
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Discussion 
 
The study shows the appearance and distribution of IGF-I mRNA and peptide during early 
development of the tilapia, O. niloticus. Both IGF-I mRNA and peptide were observed in 
parenchymal cells of all organs investigated but the onset, intensity and duration of IGF-I 
expression differed considerably among the various tissues and organs.  
Both IGF-I mRNA and peptide appeared in liver at 4 DPF. This early onset of IGF-I 
production in tilapia liver is in agreement with results obtained in shi drum where IGF-I 
immunoreactivity was detected in hepatocytes during the first week post hatching (Radaelli et 
al. 2003). Because liver is the main source of endocrine IGF-I, these results suggest a 
particular physiological impact of circulating IGF-I in early development. Although high 
expression of IGF-I mRNA was detected throughout life in tilapia liver, IGF-I-
immunoreactivity decreased with age and was present only until about 70 DPF. In contrast to 
an earlier study on sea bream (Funkenstein et al. 1997), an intense response by in situ 
hybridisation for IGF-I was obtained also in adult tilapia liver. In spite of the clear expression 
of IGF-I mRNA in adult tilapia liver (Schmid et al. 1999), no IGF-I-immunoreactive 
hepatocytes could be identified in adult barramundi (Richardson et al. 1995) and tilapia 
(Reinecke et al. 1997; Schmid et al. 1999). Similarly, in rat liver, IGF-I-immunoreactivity was 
localised only after pretreatment with colchicine (Hansson et al. 1988). Therefore, IGF-I 
might be released from fish liver into the circulation immediately after synthesis, as has 
previously been presumed in mammals (Hansson et al. 1988). 
High-affinity hepatic-binding sites for growth hormone (GH) have been identified in 
the liver of several fish species, including tilapia (Ng et al. 1992). In accordance, there is 
strong evidence that GH stimulates IGF-I expression in fish liver and its secretion into the 
circulation (see Reinecke et al. 2005). Injection or oral administration of GH significantly 
enhanced the IGF-I mRNA level in the liver of numerous species (e.g. Duan et al. 1993; 
Duguay et al. 1994, 1996; Moriyama 1995; Shamblott et al. 1995; Shepherd et al. 1997; Vong 
et al. 2003; Biga et al. 2004). The GH-induced increase in liver IGF-I mRNA expression is 
accompanied by an increase in the level of circulating IGF-I (Funkenstein et al. 1989; Niu et 
al. 1993; Moriyama et al. 2000). In addition to these in vivo studies, some in vitro 
investigations have also demonstrated the stimulating effect of GH on liver IGF-I mRNA 
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expression, i.e. on primary cultured hepatocytes of salmonids (Duan et al. 1993; Shamblott et 
al. 1995, Pierce et al. 2005) and tilapia (Schmid et al. 2000). In rainbow trout, GH mRNA was 
detected in early stage embryos (Yang et al. 1999). Thus, production and release of liver IGF-
I during tilapia early development may be under the control of GH. 
The early onset of  the production of IGF-I in tilapia gastro-intestinal tract, i.e. at 5 
DPF in intestine and at 9 DPF in stomach, supports the results of earlier studies. In the 
intestinal epithelium of turbot (Berwert et al. 1995) and shi drum (Radaelli et al. 2003), the 
first IGF-I-immunoreactive cells can be found as early as the first week post hatching. 
Furthermore, the IGF-1R appeared in the second week post hatching in shi drum gut (Radaelli 
et al. 2003). The number of IGF-I producing cells in the developing bony fish gastro-intestinal 
tract by far exceeds that in the adult because, during ontogeny, almost all epithelial cells 
throughout the gastro-intestinal tract exhibited IGF-I mRNA and peptide. The IGF-I 
immunoreactive material is mainly located in the cell apex as has also reported in shi drum 
(Radaelli et al. 2003), possibly suggesting release into the lumen. Around 17 DPF, additional 
infrequent IGF-I containing cells appear in the mucosal epithelium; these cells have the 
typical appearance of endocrine cells as characteristic for adult fish (Reinecke et al. 1997, 
Koppang et al. 1998). The distribution of these IGF-I immunoreactive cells in the various 
portions of the adult gastro-intestinal tract as well as their frequency vary largely among 
different individuals, as prevousely reported in turbot (Berwert et al. 1995) and Atlantic 
salmon (Koppang et al. 1998),  
Although the early and overall appearance of IGF-I and its receptor strongly suggest a 
particular physiological impact of IGF-I in the developing gastro-intestinal tract, we can only 
hypothesize on the physiological meaning of intestinal IGF-I in fish. IGF-I secreted from the 
IGF-I-immunoreactive epithelial cells may exert mitogenic functions by acting on 
neighbouring epithelial cells. This hypothesis is supported by results obtained in mammals. In 
pig, the amounts of intestinal IGF-I-immunoreactivity and of the IGF-1R can be correlated 
with villous growth and maturation (Schober et al. 1990) and, in adult rat, IGF-I potently 
stimulated crypt cell proliferation and villus cell density (Steeb et al. 1994). The potential 
proliferative action of intestinal IGF-I during development and adult life may be regulated by 
GH, which markedely increases the amount of intestinal IGF-I mRNA in juvenile common 
carp (Vong et al. 2003) and adult rainbow trout (Biga et al. 2004).  
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In juvenile and adult bony fish, IGF-I released from the unfrequent IGF-I-
immunoreactive mucosal epithelial cells may exert paracrine effects in response to altering 
local demands, such as repair. In agreement with this hypothesis, the therapeutical potential of 
IGF-I has been discerned for numerous acute bowel disorders resulting in accelerated 
intestinal repair and epithelial regrowth (Howarth 2003). Because, in addition to gill and 
kidney, the intestinal tract exerts important osmoregulatory functions in fish, intestinal IGF-I 
may also be involved in osmoregulation (Koppang et al. 1998; Reinecke and Collet 1998). 
This hypothesis is supported by experiments in brown trout suggesting that IGF-I plays a role 
in the regulation of intestinal Na+,K+-ATPase activity (Seidelin and Madsen 1999). 
IGF-I-immunoreactivity has been localized in cells of the exocrine parenchyma of shi 
drum and seabream larvae (Funkenstein et al. 1997; Perrot et al. 1999; Radaelli et al. 2003); 
this is supported by the results of the present study. As IGF-I production in pancreas is 
stimulated by GH in rat (Jevdjovic et al. 2004) IGF-I in fish pancreas may be also under the 
control of GH although no results have been presented to date on the potential regulation of 
IGF-I in the exocrine pancreas.  
To date, indications for the presence of IGF-I in the endocrine pancreas have only 
been obtained by immunohistochemical studies. These have shown that IGF-I 
immunoreactivity occurs in islet cells of several bony fish species (Reinecke et al. 1993, 
1997; Berwert et al. 1995; Richardson et al. 1995). The present study provides the additional 
information that IGF-I mRNA is also present in islet cells. This is supported by molecular 
biological studies that have shown that IGF-I mRNA expression in principal islets of the 
salmon O. gorbusha  (Plisetskaya et al. 1993) and of Cottus scorpius (Loffing-Cueni et al. 
1998). Islet IGF-I appeared at 6 DPF in tilapia (this study) and day 10 post hatching in turbot 
(Berwert et al. 1995) suggesting a significant physiological role for islet-derived IGF-I during 
larval development. In both species, from the onset of its expression, IGF-I occurs in non-
insulin cells. This observation is in agreement with studies on adult teleosts, such as eel, 
tilapia, goldfish, turbot and common carp (Reinecke et al. 1993, 1997; Berwert et al. 1995).  
On the one hand, islet-derived IGF-I may be involved in the paracrine regulation of 
insulin secretion from the β-cells although the evidence in mammals is conflicting (Leahy and 
Vandekerkhove 1990; Van Schravendijk et al. 1990; Jevdjovic et al. 2004). On the other 
hand, some studies suggest that islet-derived IGF-I may act as an endocrine hormone. 
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Hypophysectomy does not influence the amount of sulphation activity in eel pancreas (Duan 
and Hirano 1992) suggesting that islet IGF-I is not regulated by GH. In goby, islectomy leads 
to a decrease in 35SO4-incorporation in cartilage (Bern et al. 1991) but hepatic GH binding 
was unchanged (Kelley et al 1993). The observed effects may have been raised by insulin 
(Plisetskaya 1998). However, in addition to the GH-dependent liver IGF-I system, islet-
derived IGF-I constitutes a further endocrine GH-independent IGF-I system involved in 
regulation of fish growth. 
No information is available on IGF-I in developing fish kidney. In adult bony fish, 
however, epithelial cells mainly of the proximal tubules have been reported as sites of IGF-I 
production in tilapia (Reinecke et al. 1997), as has similarly been described in adult mammals 
(see: Reinecke and Collet 1998). In tilapia, IGF-I occurred in renal vesicles even at early 
stages of development, i.e. at 5 DPF. Later, it was present in proximal and distal tubules and 
in collecting and urinary ducts. Whereas IGF-I in the tubular sytem is detected throughout the 
cytoplasm, it occurs only in the apical cell part in the duct possibly suggesting the release of 
IGF-I into the lumen. Apart from gills, kidney is a major osmoregulatory organs in fish but 
the evidence for a potential participation of renal IGF-I in osmoregulation is conflicting. In 
rainbow trout, transfer to seawater has been reported to increase the IGF-I mRNA level in 
kidney (Sakamoto and Hirano 1993). In contrast, the same treatment did not affect the 
Na+,K+-ATPase gene level and activity in brown trout (Madsen et al. 1995) and the renal IGF-
I mRNA level in the four-spine sculpin, Cottus kazika (Inoue et al. 2003). Thus, at present we 
can only speculate about the physiological role of IGF-I in bony fish kidney. In addition to its 
possible role in osmoregulation, renal IGF-I may be involved in several other parameters of 
kidney function, such as in the stimulation of kidney growth and differentiation, renal blood 
flow, glomerular filtration rate and sodium absorption, as is likely in mammals (Hirschberg 
1996).  
In O. niloticus, IGF-I also appears early in tissues that are highly involved in growth, 
such as cartilage and skeletal muscle. At 4 DPF, IGF-I mRNA and peptide are present in the 
chondrocytes of cartilage of various location. Similarly, in shi drum IGF-I immunoreactivity 
has been observed in cartilage at day 11 post hatching (Radaelli et al. 2003). The expression 
of IGF-I in tilapia is most pronounced in growing regions. The number of IGF-I containing 
chondrocytes is higher during development than in adult life, thus underlining the 
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physiological impact of local IGF-I during cartilage growth. Although the GH/liver IGF-I axis 
is involved in the regulation of fish growth as endocrine system (Duan 1998; Reinecke et al. 
2005) an influence of GH on growth via local auto/paracrine IGF-I, as indicated by the 
present results, is also likely. An early study on eel has determined that the stimulatory effect 
of GH on sulfate incorporation into cartilage is mediated by an IGF-like plasma factor (Duan 
and Inui, 1990). In agreement, the injection of GH into coho salmon cartilage stimulates 
sulfate and thymidine incorporation (McCormick et al. 1992; Tsai et al. 1994). Thus, GH may 
have increased both uptakes via stimulation of local IGF-I, because IGF-I peptide and mRNA 
have been shown in chondrocytes of developing (Perrot et al. 1999; Radaelli et al. 2003; this 
study) and adult (Funkenstein et al. 1997; Reinecke et al. 1997) bony fish. The GH-dependent 
growth promoting effects of IGF-I on cartilage may therefore be exerted not only via the 
endocrine route, but also in an autocrine/paracrine manner by IGF-I released from local 
chondrocytes, as it has been shown in rat (Reinecke et al. 2000). 
In contrast to skeletal muscle of young shi drum larvae (Radaelli et al. 2003) in which 
no IGF-I immunoreactivity has been detected, the onset of IGF-I production in tilapia skeletal 
muscle occurs at 4 DPF, with IGF-I showing a maximum around 10-29 DPF, decreasing 
afterwards but persisting throughout life. In agreement with an auto/paracrine function of 
muscle IGF-I, IGF-I receptor number and binding in trout skeletal muscle are highest at 5 
weeks and both parameters decrease with age (Mendez et al. 2001). Furthermore, a parallel 
age-related decline has been found for tyrosine kinase activity for the IGF-1R (Mendez et al. 
2001). In rainbow trout muscle in vitro, IGF-I has been shown to be highly effective in 
stimulating glucose and alanine uptake into myosatellite cells whereby the degree of 
stimulation changed when cells differentiated to myotubes (Castillo et al. 2004). These and 
the present results showing that IGF-I in skeletal muscle appears already at 4 DPF and 
decreases with age indicate a key role for IGF-I in muscle development. IGF-I may be 
associated in later life with metabolism and repair mechanisms. In adult rainbow trout, the 
expression of IGF-I in skeletal muscle is stimulated by GH (Biga et al. 2005). Thus, GH may 
also regulate IGF-I production in larval musle. 
Endocrine (liver-derived) IGF-I seems to have a physiological impact in 
smoltification. In mummichog (Fundulus heteroclitus; Mancera and McCormick 1998) and 
trout (Seidelin et al. 1999), IGF-I improves adaptation to seawater in a dose-dependent 
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manner. The osmoregulatory effects of IGF-I seem to be exerted directly because, in 
preparations of Coho salmon gills in vitro, IGF-I stimulates Na+,K+-ATPase (Madsen and 
Bern 1993). Hypophysectomy in tilapia lowers the levels of gill Na+, K+-ATPase when 
compared with sham-operated controls (Shepherd et al. 1997) indicating an involvement of 
the GH/liver IGF-I axis. In agreement, in a study on Cottus kazika, the levels of liver IGF-I 
mRNA hass been shown to be significantly higher in individuals reared in seawater than in 
those reared in freshwater (Inoue et al. 2003). In sharp contrast, a study on Coho salmon IGF-
I mRNA has demonstrated that IGF-I mRNA is not significantly altered during seawater 
adaptation in liver but markedly increased in gills (Sakamoto and Hirano 1993). The chloride 
cells of filament epithelium have been shown not only to express Na+,K+-ATPase in trout 
(McCormick 1996) but also IGF-I in tilapia (this study), in shi drum larvae (Radaelli et al. 
2003) and in adult tilapia  (Reinecke et al. 1997). GH receptors have been detected in tilapia 
gills (Fryer et al. 1979) and GH treatment increases IGF-I mRNA in gills of salmonids and 
carp (Vong et a. 2003; Biga et al. 2004). Thus, in addition to circulating IGF-I, GH-regulated 
local autocrine/paracrine IGF-I in the chloride cells seems to participate in the regulation of 
plasma osmolality and gill Na+,K+-ATPase activity. Because the expression of IGF-I in tilapia 
gill chloride cells was detected even around 6-7 DPF, IGF-I may exert additional functions, 
such as influencing the growth and maintenance of the filament epithelium. 
In shi drum heart, IGF-I immunoreactivity was detected in 15-day larvae (Radaelli et 
al 2003). Likewise, IGF-I mRNA and peptide appear at 13 DPF in tilapia. The expression of 
IGF-I in cardiomyocytes is clearly detectable until 70 DPF but is absent from later stages and 
adults indicating a particular physiological impact of IGF-I during heart development and 
growth. In correlation, a significant increase in IGF-1R mRNA levels (Gutierrez et al. 1995) 
has been observed in the rapidly growing juvenile trout heart (Greene and Chen 1999). In fish 
heart, local IGF-I may be even more important than circulating IGF-I. In rainbow trout heart 
IGF-1R mRNA levels decreased after application of GH (Biga et al. 2004) and the number of 
IGF-I receptors was inversely related to the concentration of circulating IGF-I (Banos et al. 
1997; Moon et al. 1996).  
Screening studies have identified the potential sites of IGF-I synthesis in the brains of 
barramundi, tilapia and sea bream. IGF-I-immunoreactive neurones are present in adult 
barramundi brainstem (Richardson et al. 1995) and at all levels of adult tilapia brain 
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(Reinecke et al. 1997). Correspondingly, IGF-I mRNA signals have been described 
throughout the brain of developing sea bream (Funkenstein et al 1997). The functional impact 
of IGF-I in brain is indicated by the presence of IGF-1R in adult carp and trout brain (Leibush 
et al. 1996) and by the appearence of IGF-1R-immunoreactivity in the developing brain of shi 
drum as early as hatching (Radaelli et al. 2003). In contrast to IGF-II (Caelers et al. 2003), the 
exact distribution of the IGF-I gene expression in fish brain is unknown. the IGF-I-
immunoreactive neurones in barramundi and tilapia are sparsely scattered and their 
distribution exhibits pronounced inter-individual differences. In juvenile (this study) and adult 
tilapia (Reinecke et al. 1997) and adult daddy sculpin (Loffing-Cueni et al. 1998) brain, only 
IGF-I producing Purkinje cells in cerebellum are constantly present. In agreement with the 
potential autocrine/paracrine action of neuronal IGF-I in adult brown trout, Salmo trutta, IGF-
I binding in the brain is highest in the cerebellum (Smith et al. 2005). The pronounced inter-
individual variations of IGF-I producing neurones in adult fish brain make a neurotransmitter 
or -modulator function of IGF-I unlikely. Rather, neuronal IGF-I may support the survival of 
neurones and glia cells, as it is also likely for mammals (Cheng et al. 2001). During 
development, IGF-I may stimulate neurogenesis, dendritic growth and synaptogenesis in an 
autocrine/paracrine manner, as has been shown in mammals (e.g. Zhou et al. 1999; Niblock et 
al. 2000; Kakizawa et al. 2003). This hypothesis is supported by the observation that, in early 
developing tilapia larvae, most neurones expressed IGF-I mRNA and that the number of 
neurones containing IGF-I mRNA decreases with age. Whether the assumed actions of IGF-I 
are exerted under the control of GH is unclear at present, since GH significantly increased 
brain IGF-I mRNA in rainbow trout (Biga et al. 2004), whereas no effect has been reported in 
common carp (Vong et al. 2003). 
The present study is the first to show that IGF-I occurs in the bony fish pituitary. IGF-I  
was observed in both the neuro- and adenopituitary. In the posterior part, neurosecretory 
axons containing IGF-I-immunoreactivity appear around 17 DPF, whereas no IGF-I mRNA is 
detected at this stage. The likely source of  IGF-I in the neuropituitary is the neuronal 
perikarya that lie within the hypothalamus and that exhibit IGF-I immunoreactivity. In the 
adenopituitary, IGF-I mRNA was first detected at 20 DPF. IGF-I immunoreactivity and 
mRNA in endocrine cells are present throughout development. To date, IGF-I-
immunoreactivity has only been localized in the anterior pituitary of the frog Xenopus laevis 
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in which it occurs in co-existence with prolactin (David et al. 2000). Because IGF-I binding 
sites have also been found in X. laevis anterior pituitary, IGF-I from the prolactin cells has 
been postulated to regulate GH in a paracrine manner (David et al. 2000). Whether this 
hypothesis also applies for bony fish remains to be clarified, as does the type of endocrine 
cells producing IGF-I.  
At 5 DPF, IGF-I was detected in cells of the epidermis of tilapia. The number of IGF-I 
producing epidermal cells first increases with age reaching the highest level around 19-29 
DPF. In older larvae and adults, some superficial and basal epidermal cells exhibit IGF-I 
immunoreactivity or IGF-I mRNA. In developing skin of shi drum, IGF-1R immunoreactivity 
is detectable even at hatching (Radaelli et al. 2003). The early appearance of both IGF-I and 
its receptor suggests an important auto/paracrine function of IGF-I in skin development. 
Because some IGF-I producing cells still occur in the basal and superficial layers in juvenile 
and adult tilapia and as high levels of IGF receptor mRNA were found in adult gilthead 
seabream skin (Perrot et al. 1999), local IGF-I in fish skin seems to play a role in later life. 
Skin IGF-I might be involved in repair mechanisms and wound healing as it has been 
proposed in mammals (Edmundson et al. 2003). 
In summary, the expression of IGF-I is more pronounced during ontogeny than in 
juvenile and adult life in the parenchymal cells of most of the organs investigated, such as 
epithelial cells of the gastro-intestinal tract, acinar cells of the exocrine pancreas, skeletal 
muscle cells, cardiomyocytes, renal tubular cells, neurones of the central and peripheral 
nervous system and skin cells. These results suggest a high functional impact of local IGF-I in 
early fish growth, metabolism and organogenesis by auto/paracrine means of regulation. 
Whether IGF-I expression in the early development of fish is regulated by GH remains to be 
clarified (Perrot et al. 1999; Deane et al. 2003), although low levels of GH mRNA have been 
detected as early as gastrulation in rainbow trout and intermediate amounts of GH mRNA 
have been observed in early cleavage-stage embryos (Yang et al. 1999).  
 
 
 
 
 
   71
References 
 
Ayson FG, de Jesus EG, Moriyama S, Hyodo S, Funkenstein B, Gertler A, Kawauchi H 
(2002) Differential expression of insulin-like growth factor I and II mRNAs during 
embryogenesis and early larval development in rabbitfish, Siganus guttatus. Gen Comp 
Endocrinol 126:165-174  
Banos N, Moon TW, Castejon C, Gutierrez J, Navarro I (1997) Insulin and insulin-like 
growth factor-I (IGF-I) binding in fish red muscle: regulation by high insulin levels. Regul 
Pept 68:181-187 
Baroiller JF, Desprez D, Carteret Y, Tacon P, Hoareau MC, Mélard C, Jalabert B (1997) 
Influence of environmental and social factors on the reproductive efficiency in three tilapia 
species, Oreochromis niloticus, O. aureus and the red tilapia (Red Florida strain). In: 
Fitzsimmons K (eds), Proceedings of the fourth International Symposium on Tilapia in 
Aquaculture, 9-12 November 1997, Orlando, Florida. U.S.A., pp 238-252 
Bern HA, McCormick SD, Kelley KM, Gray ES, Nishioka RS, Madsen SS, Tsai PL (1991) 
Insulin-like growth factors "under water": role in growth and function of fish and other 
poikilothermic vertebrates. In: Spencer EM (ed) Modern concepts of insulin-like growth 
factors. Elsevier, New York, pp 85-96 
Berwert L, Segner H, Reinecke M (1995) Ontogeny of IGF-1 and the classical islet hormones 
in the turbot, Scophthalmus maximus. Peptides 16:113-122  
Biga PR, Schelling GT, Hardy RW, Cain KD, Overturf K, Ott TL (2004) The effects of 
recombinant bovine somatotropin (rbST) on tissue IGF-I, IGF-I receptor, and GH mRNA 
levels in rainbow trout, Oncorhynchus mykiss. Gen Comp Endocrinol 135:324-323 
Caelers A, Schmid AC, Hrusovsky A, Reinecke M (2003) Insulin-like growth factor II 
mRNA is expressed in neurones of the brain of the bony fish Oreochromis mossambicus, the 
tilapia. Eur J Neurosci 18:355-363 
   72 
Caelers A, Berishvili G, Meli ML, Eppler E, Reinecke M (2004) Establishment of a real-time 
RT-PCR for the determination of absolute amounts of IGF-I and IGF-II gene expression in 
liver and extrahepatic sites of the tilapia. Gen Comp Endocrinol 137:196-204 
Castillo J, Codina M, Martinez ML, Navarro I, Gutierrez J (2004) Metabolic and mitogenic 
effects of IGF-I and insulin on muscle cells of rainbow trout. Am J Physiol Regul Integr 
Comp Physiol 286:R935-R941 
Cheng CM, Cohen M, Tseng V, Bondy CA (2001) Endogenous IGF1 enhances cell survival 
in the postnatal dentate gyrus. J Neurosci Res 64:341-347 
Chourrout D, Itskovich J (1983) Three manipulations permitted by artificial insemination in 
tilapia: induced diploid gynogenesis, production of all triploid population and intergeneric 
hybridisation. In: Fishelson L, Yaron Z (eds) International Symposium on Tilapia in 
Aquaculture, Nazareth, Israel, pp 246-255 
David I, Bosshard R, Kloas W, Reinecke M (2000) Insulin-like growth factor I in the anterior 
pituitary of the clawed frog Xenopus laevis: immunocytochemical and autoradiographic 
indication for a paracrine action and corelease with prolactin. J Neuroendocrinol 12:415-420 
Deane EE, Kelly SP, Collins PM, Woo NY (2003) Larval development of silver sea bream 
(Sparus sarba): ontogeny of RNA-DNA ratio, GH, IGF-I, and Na(+)-K(+)-ATPase. Mar 
Biotechnol (NY) 5:79-91 
Duan C (1998) Nutritional and developmental regulation of insulin-like growth factors in fish. 
J Nutr 128:306S-314S 
Duan C, Hirano T (1992) Effects of insulin-like growth factor-I and insulin on the in-vitro 
uptake of sulphate by eel branchial cartilage: evidence for the presence of independent hepatic 
and pancreatic sulphation factors. J Endocrinol 133:211-219 
Duan C, Duguay SJ, Plisetskaya EM (1993) Insulin-like growth factor I (IGF-I) mRNA 
expression in coho salmon, Oncorhynchus kisutch: tissue distribution and effects of growth 
hormone/prolactin family protein. Fish Physiol. Biochem 11:371-379 
   73
Duan C, Plisetskaya EM, Dickhoff WW (1995) Expression of insulin-like growth factor I in 
normally and abnormally developing coho salmon (Oncorhynchus kisutch). Endocrinology 
136:446-452 
Duan CM, Inui Y (1990) Effects of recombinant eel growth hormone on the uptake of 
[35S]sulfate by ceratobranchial cartilages of the Japanese eel, Anguilla japonica. Gen Comp 
Endocrinol 79:320-325 
Duguay SJ, Swanson P, Dickhoff WW (1994) Differential expression and hormonal 
regulation of alternatively spliced IGF-I mRNA transcripts in salmon. J Mol Endocrinol 
12:25-37  
Duguay SJ, Lai-Zhang J, Steiner DF, Funkenstein B, Chan SJ (1996) Developmental and 
tissue-regulated expression of IGF-I and IGF-II mRNAs in Sparus aurata. J Mol Endocrinol 
16:123-132 
Edmondson SR, Thumiger SP, Werther GA, Wraight CJ (2003) Epidermal homeostasis: the 
role of the growth hormone and insulin-like growth factor systems. Endocr Rev 24:737-764 
Fryer JN (1979) A radioreceptor assay for purified teleost growth hormone. Gen Comp 
Endocrinol 39:123-130  
Funkenstein B, Silbergeld A, Cavari B, Laron Z (1989) Growth hormone increases plasma 
levels of insulin-like growth factor (IGF-I) in a teleost, the gilthead seabream (Sparus aurata). 
J Endocrinol 120:R19-R21 
Funkenstein B, Almuly R, Chan SJ (1997) Localization of IGF-I and IGF-I receptor mRNA in 
Sparus aurata larvae. Gen Comp Endocrinol 107:291-303 
Greene MW, Chen TT (1997) Temporal expression pattern of insulin-like growth factor 
mRNA during embryonic development in a teleost, rainbow trout (Onchorynchus mykiss). 
Mol Mar Biol Biotechnol 6:144-151 
 
   74 
Greene MW, Chen TT (1999) Quantitation of IGF-I, IGF-II, and multiple insulin receptor 
family member messenger RNAs during embryonic development in rainbow trout. Mol 
Reprod Dev 54:348-356 
Gutiérrez J, Parrizas M, Maestro MA, Navarro I, Plisetskaya EM (1995) Insulin and IGF-I 
binding and tyrosine kinase activity in fish heart. J Endocrinol 146:35-44 
Hansson H-A, Nilsson A, Isgaard J, Billig H, Isaksson O, Skottner A, Andersson IK, Rozell B 
(1988) Immunohistochemical localization of insulin-like growth factor I in the adult rat.  
Histochemistry 89:403-410 
Hirschberg R (1996) Insulin-like growth factor I in the kidney. Miner Electrolyte Metab 
22:128-132 
Howarth GS (2003) Insulin-like growth factor-I and the gastrointestinal system: therapeutic 
indications and safety implications. J Nutr 133:2109-2112 
Inoue K, Iwatani H, Takei Y (2003) Growth hormone and insulin-like growth factor I of a 
Euryhaline fish Cottus kazika: cDNA cloning and expression after seawater acclimation. Gen 
Comp Endocrinol 131:77-84 
Jevdjovic T, Maake C, Eppler E, Zoidis E, Reinecke M, Zapf J (2004) Effects of insulin-like 
growth factor-I treatment on the endocrine pancreas of hypophysectomized rats: comparison 
with growth hormone replacement. Eur J Endocrinol 151:1-10  
Kakizawa S, Yamada K, Iino M, Watanabe M, Kano M (2003) Effects of insulin-like growth 
factor I on climbing fibre synapse elimination during cerebellar development. Eur J Neurosci 
17:545-554 
Kelley KM, Gray ES, Siharath K, Nicoll CS, Bern HA (1993) Experimental diabetes mellitus 
in a teleost fish. II. Roles of insulin, growth hormone (GH), insulin-like growth factor-I, and 
hepatic GH receptors in diabetic growth inhibition in the goby, Gillichthys mirabilis. 
Endocrinology 132:2696-2702 
   75
Koppang EO, Thomas GA, Ronningen K, Press CMcL (1998) Expression of insulin-like 
growth factor-I in the gastrointestinal tract of Atlantic salmon (Salmo salar L.). Fish Physiol 
Biochem 18:167-175 
Leahy JL, Vandekerkhove KM (1990) Insulin-like growth factor-I at physiological 
concentrations is a potent inhibitor of insulin secretion. Endocrinology 126:1593-1598 
Leibush B, Parrizas M, Navarro I, Lappova Y, Maestro MA, Encinas M, Plisetskaya EM, 
Gutiérrez J (1996) Insulin and insulin-like growth factor-I receptors in fish brain. Peptides 
61:155-161 
Loffing-Cueni D, Schmid AC, Graf H, Reinecke M (1998) IGF-I in the bony fish Cottus 
scorpius: cDNA, expression and differential localization in brain and islets. Mol Cell 
Endocrinol 141:187-194 
Madsen SS, Bern HA (1993) In-vitro effects of insulin-like growth factor-I on gill Na+,K(+)-
ATPase in coho salmon, Oncorhynchus kisutch. J Endocrinol 138:23-30 
Madsen SS, Jensen MK, Nhr J, Kristiansen K (1995) Expression of Na(+)-K(+)-ATPase in 
the brown trout, Salmo trutta: in vivo modulation by hormones and seawater. Am J Physiol 
269:R1339-R1345 
Mancera JM, McCormick SD (1998) Evidence for growth hormone/insulin-like growth factor 
I axis regulation of seawater acclimation in the euryhaline teleost Fundulus heteroclitus. 
Gen Comp Endocrinol 111:103-112 
McCormick SD (1996) Effects of growth hormone and insulin-like growth factor I on salinity 
tolerance and gill Na+, K+-ATPase in Atlantic salmon (Salmo salar): interaction with 
cortisol. Gen Comp Endocrinol 101:3-11 
McCormick SD, Tsai PI, Kelley KM, Nishioka RS, Bern HA (1992) Hormonal control of 
sulfate uptake by branchial cartilage of coho salmon: role of IGF-I. J Exp Zool 262:166-171 
 
   76 
Mendez E, Smith A, Figueiredo-Garutti ML, Planas JV, Navarro I, Gutiérrez J (2001) 
Receptors for insulin-like growth factor-I (IGF-I) predominate over insulin receptors in 
skeletal muscle throughout the life cycle of brown trout, Salmo trutta. Gen Comp Endocrinol 
122:148-157 
Moon TW, Castejon C, Banos N, Maestro MA, Plisetskaya EM, Gutiérrez J, Navarro I (1996) 
Insulin and IGF-I binding in isolated trout cardiomyocytes. Gen Comp Endocrinol 103:264-
272 
Moriyama S (1995) Increased plasma insulin-like growth factor-I (IGF-I) following oral and 
intraperitoneal administration of growth hormone to rainbow trout, Oncorhynchus mykiss. 
Growth Regul. 5:164-167 
Moriyama S, Ayson FG, Kawauchi H (2000) Growth regulation by insulin-like growth factor-
I in fish. Biosci Biotechnol Biochem 64:1553-1562 
Ng TB, Leung TC, Cheng CHK, Woo NYS (1992) Growth hormone binding sites in tilapia 
(Oreochromis mossambicus) liver. Gen Comp Endocrinol  86:111-118 
Niblock MM, Brunso-Bechtold JK, Riddle DR (2000) Insulin-like growth factor I stimulates 
dendritic growth in primary somatosensory cortex. J Neurosci 20:4165-4176 
Niu PD, Pérez-Sanchez J, Le BailPY (1993) Development of a protein-binding assay for 
teleost insulin-like growth-factor (IGF)-like relationhips between growth-hormone (GH) and 
IGF-I in the blood of rainbow trout (Oncorhynchus mykiss). Fish Physiol Biochem 11:381-
391 
Perrot V, Moiseeva EB, Gozes Y, Chan SJ, Ingleton, P, Funkenstein B (1999) Ontogeny of 
the insulin-like growth factor system (IGF-I, IGF-II, and IGF-1R) in gilthead seabream 
(Sparus aurata): expression and cellular localization. Gen Comp Endocrinol 116:445-460 
Pierce AL, Fukada H, Dickhoff WW (2005) Metabolic hormones modulate the effect of 
growth hormone (GH) on insulin-like growth factor-I (IGF-I) mRNA level in primary culture 
of salmon hepatocytes. J Endocrinol 184:341-349 
   77
Plisetskaya EM (1998) Some of my not so favorite things about insulin and insulin-like 
growth factors in fish. Comp Biochem Physiol B 121:3-11 
Plisetskaya EM, Bondareva VM, Duan C, Duguay SJ (1993) Does salmon brain produce 
insulin? Gen Comp Endocrinol 91:74-80 
Pozios KC, Ding J, Degger B, Upton Z, Duan C (2001) IGFs stimulate zebrafish cell 
proliferation by activating MAP kinase and PI3-kinase-signaling pathways. Am J Physiol 
Regul Integr Comp Physiol 280:R1230-R1239 
Radaelli G, Domeneghini C, Arrighi S, Bosi G, Patruno M, Funkenstein B (2003) 
Localization of IGF-I, IGF-I receptor, and IGFBP-2 in developing Umbrina cirrosa (Pisces: 
Osteichthyes). Gen Comp Endocrinol 130:232-244 
Reinecke M, Collet C (1998) The phylogeny of the insulin-like growth factors. Int Rev Cytol 
183:1-94 
Reinecke M, Maake C, Falkmer S, Sara VR (1993) The branching of insulin-like growth 
factor 1 and insulin: an immunohistochemical analysis during phylogeny. Regul Pept 48:65-
76 
Reinecke M, Schmid A, Ermatinger R, Loffing-Cueni D (1997) Insulin-like growth factor I in 
the teleost Oreochromis mossambicus, the tilapia: Gene sequence, tissue expression, and 
cellular localization. Endocrinology 138:3613- 3619  
Reinecke M, Schmid AC, Heyberger-Meyer B, Hunziker EB, Zapf J (2000) Effect of growth 
hormone and insulin-like growth factor I  (IGF-I) on the expression of IGF-I mRNA and 
peptide in rat tibial growth plate and articular chondrocytes in vivo. Endocrinology 141:2847-
2853 
Reinecke M, Björnsson BT, Dickhoff WW, McCormick SD, Navarro I, Power DM, Gutiérrez 
J (2005) Growth hormone and insulin-like growth factors in fish: Where we are and where to 
go. Gen Comp Endocrinol 142:20-24 
   78 
Richardson NA, Anderson AJ, Rimmer MA, Sara VR (1995) Localization of insulin-like 
growth factor-I immunoreactivity in larval and juvenile barramundi (Lates calcarifer). Gen 
Comp Endocrinol 100:282-292 
Sakamoto T, Hirano T (1993) Expression of insulin-like growth factor I gene in 
osmoregulatory organs during seawater adaptation of the salmonid fish: possible mode of 
osmoregulatory action of growth hormone. Proc Natl Acad Sci U S A 90:1912-1916 
Schmid AC, Naf E, Kloas W, Reinecke M (1999) Insulin-like growth factor-I and -II in the 
ovary of a bony fish, Oreochromis mossambicus, the tilapia: in situ hybridisation, 
immunohistochemical localisation, Northern blot and cDNA sequences. Mol Cell Endocrinol 
156:141-149 
Schmid AC, Reinecke M, Kloas W (2000) Primary cultured hepatocytes of the bony fish, 
Oreochromis mossambicus, the tilapia: a valid tool for physiological studies on IGF-I 
expression in liver. J Endocrinol 166:265-273 
Schober DA, Simmen FA, Hadsell DL, Baumrucker CR (1990) Perinatal expression of type I 
IGF receptors in porcine small intestine. Endocrinology 126:1125-1132 
Segner H, Storch V, Reinecke M, Kloas W, Hanke W (1994) The development of functional 
digestive and metabolic organs in turbot, Scophthalmus maximus. Mar Biol 119:471-486 
Seidelin M, Madsen SS (1999) Endocrine control of Na+,K+-ATPase and chloride cell 
development in brown trout (Salmo trutta): interaction of insulin-like growth factor-I with 
prolactin and growth hormone. J Endocrinol 162:127-135 
Seidelin M, Madsen SS, Byrialsen A, Kristiansen K (1999) Effects of insulin-like growth 
factor-I and cortisol on Na+, K+-ATPase expression in osmoregulatory tissues of brown trout 
(Salmo trutta). Gen Comp Endocrinol 113:331-342 
Shamblott MJ, Chen TT (1993) Age-related and tissue-specific levels of five forms of insulin-
like growth factor mRNA in a teleost. Mol Mar Biol Biotechnol 2:351-361 
   79
Shamblott MJ, Cheng CM, Bolt D, Chen TT (1995) Appearance of insulin-like growth factor 
mRNA in the liver and pyloric ceca of a teleost in response to exogenous growth hormone. 
Proc Natl Acad Sci U S A 92:6943-6946 
Shepherd BS, Sakamoto T, Nishioka RS, Richman NH, Mori I, Madsen SS, Chen TT, Hirano 
T, Bern HA, Grau EG (1997) Somatotropic actions of the homologous growth hormone and 
prolactins in the euryhaline teleost, the tilapia, Oreochromis mossambicus. Proc Natl Acad Sci 
U S A 94:2068-2072 
Shved N, Berishvili G, D’Cotta H, Baroiller JF, Eppler E, Segner H, Reinecke M (2005) A 
survey on the expression of IGF-I in the early developing bony fish with special emphasis on 
the tilapia, Oreochromis niloticus. Ann N Y Acad Sci 1040:469–471 
Smith A, Chan SJ, Gutierrez J (2005) Autoradiographic and immunohistochemical 
localization of insulin-like growth factor-I receptor binding sites in brain of the brown trout, 
Salmo trutta. Gen Comp Endocrinol 141:203–213 
Steeb CB, Trahair JF, Tomas FM, Read LC (1994) Prolonged administration of IGF peptides 
enhances growth of gastrointestinal tissues in normal rats. Am J Physiol 266:G1090-G1098 
Tsai PI, Madsen SS, McCormick SD, Bern HA (1994) Endocrine control of cartilage in coho 
salmon: GH influence in vivo on the response to IGF-I in vitro. Zool Sci 11:299-303 
Van Schravendijk CF, Heylen L, Van den Brande JL, Pipeleers DG (1990) Direct effect of 
insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic beta cells. 
Diabetologia 33:649-653 
Vong QP, Chan KM, Cheng CH (2003) Quantification of common carp (Cyprinus carpio) 
IGF-I and IGF-II mRNA by real-time PCR: differential regulation of expression by GH. J 
Endocrinol 178:513-521 
Wood AW, Duan C, Bern HA (2005) Insulin-like growth factor signaling in fish. Int Rev 
Cytol 243:215-285 
   80 
Yang BY, Greene M, Chen TT (1999) Early embryonic expression of the growth hormone 
family protein genes in the developing rainbow trout, Oncorhynchus mykiss. Mol Reprod Dev 
53:127-134 
Zhou X, Herman JP, Paden CM (1999) Evidence that IGF-I acts as an autocrine/paracrine 
growth factor in the magnocellular neurosecretory system: neuronal synthesis and induction 
of axonal sprouting. Exp Neurol 159:419-432 
   81
Chapter 2 
 
Differential expression of IGF-I mRNA and peptide in the male and female gonad 
during early development of a bony fish, the tilapia Oreochromis niloticus*
 
Insulin-like growth factor I (IGF-I) plays a key role in the complex system that regulates bony 
fish growth, differentiation, and reproduction. The major source of circulating IGF-I is liver, but 
IGF-I-producing cells also occur in other organs, including the gonads. Because no data are 
available on the potential production sites of IGF-I in gonad development, developmental stages 
of monosex breedings of male and female tilapia from 0 day post fertilization (DPF) to 90 DPF 
were investigated for the production sites of IGF-I at the peptide (immunohistochemistry) and 
mRNA (in situ hybridization) level. IGF-I mRNA first appeared in somatic cells of the male 
and female gonad anlage at 7 DPF followed by IGF-I peptide around 9-10 DPF. Gonad anlagen 
were detected from 7 DPF. Starting at 7 DPF, IGF-I peptide but no IGF-I mRNA was observed 
in male and female primordial germ cells (PGCs) provided that IGF-I mRNA was not under the 
detection level, this observation may suggest that IGF-I originates from the somatic cells and is 
transferred to the PGCs or is of maternal origin. While in female germ cells IGF-I mRNA and 
peptide appeared at 29 DPF, in male germ cells both were detected as late as at 51–53 DPF. It is 
assumed that the production of IGF-I in the germ cells is linked to the onset of meiosis that in 
tilapia ovary starts at around 28 DPF and in testes at around 52–53 DPF. In adult testis, IGF-I 
mRNA and peptide occurred in the majority of spermatogonia and spermatocytes as well as in 
Leydig cells, the latter indicating a role of IGF-I in the synthesis of male sex steroids. In adult 
ovary, IGF-I mRNA and IGF-I peptide were always present in small and previtellogenic 
oocytes but only IGF-I peptide infrequently occurred in oocytes at the later stages. IGF-I 
expression appeared in numerous granulosa and some theca cells of follicles at the lipid stage 
and persisted in follicles with mature oocytes. The results suggest a crucial role of local IGF-I in 
the formation, differentiation and function of tilapia gonads.  
_________________________ 
* Berishvili G, D'Cotta H, Baroiller JF, Segner H, Reinecke M. Gen Comp Endocrinol. 2006 
May 1;146(3):204-10 
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Introduction 
 
In fish, as in other vertebrates, the main regulators of gonadal sex differentiation appear to be 
steroid hormones (Nakamura et al., 1998; Piferrer, 2001). The early still undifferentiated 
gonad anlage of fish already possesses the capability of producing gender-specific steroids. 
However, sex steroids probably are not the only factors involved because recent evidence 
indicates that they interact with other hormonal factors in sex differentiation (Piferrer, 2001). 
Sexual differentiation goes along with cell proliferation and tissue growth (Nakamura et al., 
1998). Thus, growth factors, especially insulin-like growth factor I (IGF-I) that exerts 
numerous essential functions in fish (see: Reinecke and Collet, 1998, Reinecke et al., 2005; 
Wood et al., 2005) may also be involved in fish gonadal development. IGF-I either may be a 
mediator of steroid actions or supplement the steroid effects in a quite independent manner 
under the control of growth hormone (GH). In this respect, the localisation of IGF-I and its 
receptor, the IGF-1R, in adult male, and female gonads of fish (Le Gac et al., 1996; Schmid et 
al., 1999; Perrot et al., 2000) indicates a functional impact of IGF-I in mature fish gonads.   
 Few studies have dealt with the ontogeny of IGF-I in fish. Most of them have used 
radioimmunological (Duan et al., 1995) or molecular biological techniques (Shamblott and 
Chen, 1993; Greene and Chen, 1997, 1999; Ayson et al., 2002; Deane et al., 2003). Although 
these investigations cannot give any information on the producing cells they suggest a 
functional role of IGF-I in developing fish. Furthermore, morphological studies on IGF-I 
using immunohistochemistry and/or in situ hybridisation (Richardson et al., 1995; 
Funkenstein et al., 1997; Perrot el al., 1999; Radaelli et al., 2003) have examined IGF-I 
ontogeny in various organs, however, to date IGF-I ontogeny in the gonads has not been 
investigated. 
 Because no information is available on the potential production sites of IGF-I in fish 
gonad during larval development, male and female early developmental stages of monosex 
tilapia (Oreochromis niloticus), i.e., from 0 day post fertilization (DPF) to 90 DPF, as well as 
adult individuals were investigated. The study uses immunohistochemistry to localize the 
IGF-I peptide and in situ hybridization for the presence of IGF-I mRNA. 
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Materials and methods 
 
Animals 
Monosex breedings of O. niloticus generated as described before (Baroiller et al., 1999) were 
used for this study. Fish larvae of both sexes at different developmental stages, i.e., from 0 to 
90 days postfertilization (DPF), as well as adults were sampled and anaesthetized with 2-
phenoxy-ethanol (Sigma, St. Louis, MO, USA) added to water. With the earliest stages, the 
trunk was cut to allow fixation solution to enter. From 70 DPF on, gonad samples were 
excised. Tissue preparations for in situ hybridization were fixed by immersion with 4% 
buffered paraformaldehyde (PFA) in phosphate-buffered saline (PBS), and those for 
immunohistochemistry with Bouin’s solution without acetic acid for 4 h at room temperature. 
Specimens were dehydrated in ascending series of ethanol and routinely embedded in 
paraplast (58 °C). 
 
Generation of tilapia specific probes 
Probes used for in situ hybridization were prepared as already described (Schmid et al., 1999). 
In brief, total RNA from tilapia liver was extracted by the phenol/chloroform method with the 
Ultraspec Extraction Kit (ams, Lugano, Switzerland). For cDNA synthesis, 5 μg RNA was 
annealed with 1 μM of a poly(dT) primer (5′-CCTGAATTCTAGAGCTCAT(dT17)-3′) for 
3 min at 70 °C. The RNA/primer mix was incubated for 1 h at 37 °C with 15 mM dNTPs and 
10 U AMV-reverse transcriptase (Pharmacia, Switzerland) in 1× reaction buffer (50 mM 
Tris–HCl, pH 8.3, 40 mM KCl, and 6 mM MgCl2). One microliter of cDNA was incubated 
with 1 μM of the sense (5′-GTCTGTGGAGAGCGAGGCTTT-3′) and antisense primer (5′-
AACCTTGGGTGCTCTTGGCATG-3′), corresponding to the B- and E-Domains, 200 μM 
dNTPs, and 1 U Taq-polymerase (Pharmacia) in 1× incubation buffer (10 mM Tris–HCl, pH 
8, 50 mM KCl, 1.5 mM MgCl2, and 0.001% gelatine). The amplification program was 
optimized for a Stratagene RoboCycler Gradient 40 as follows: one cycle of 10 min at 94 °C, 
1 min at 59 °C, 2 min at 72 °C; 30 cycles of 1 min at 94 °C, 1 min at 59 °C, and 2 min at 
72 °C followed by a final extension step of 5 min at 72 °C. PCR fragments were separated on 
a 2% agarose gel and eluted by the Gel Extraction Kit QIAquick (Qiagen). PCR products 
were cloned in a pCR-Script SK(+) cloning vector (Stratagene, Heidelberg, Germany). 
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Plasmids with the IGF-I fragment were sequenced (Microsynth, Switzerland) and the 
sequences compared to database. The Escherichia coli cells containing the plasmids were kept 
in glycerol stock vials. Traces of E. coli cells were removed with a sterile pipette tip, stroked 
out on 1.5% Luria–Bertani (LB)-agar plates containing ampicillin (100 μg/ml) and the plates 
incubated at 37 °C overnight. From each plate a single colony was picked and inoculated in 
5 ml LB medium containing ampicillin. After growth for 8 h the starter culture was diluted 
1:500 in LB medium and expanded with vigorous shaking overnight. The bacterial pellet was 
harvested by centrifugation at 6000g for 15 min at 4 °C. 
 Plasmids were purified using the Midi Purification Kit (Qiagen). The plasmids 
containing the specific inserts of IGF-I (207 bp), were used as templates for the synthesis of 
the digoxigenin (DIG)-labeled RNA probes. Linearization was performed with the restriction 
enzymes EcoRI for T3 polymerase-driven transcription and NotI for T7 polymerase-driven 
transcription. After ethanol precipitation, linearization efficiency was assured on a 1.2% 
agarose gel by loading 1 μg of linearized plasmid and comparison with a 1 kb DNA ladder 
(Promega). One microgram of the linearized plasmids was transcribed from the T3 and T7 
promotors to obtain the antisense and sense probes, using the in vitro transcription kit (Roche 
Diagnostics, Germany) in the presence of DIG-UTP. Integrity of probes and efficiency of 
labelling were confirmed by gel electrophoresis, including blotting and incubation with 
antibody (Ab), and by dot blot. For dot blot, 1 μl of different dilutions (undiluted, 1:10, 1:100, 
and 1:1000) of probes and control RNAs were dropped on a nylon membrane (Roche 
Diagnostics) and fixed by UV cross-linking (254 nm, 125 mJ). The membrane was washed 
with 1% blocking reagent (Roche Diagnostics) in buffer P1 for 30 min followed by treatment 
with the alkaline phosphatase (AP)-coupled anti-DIG Ab (Roche Diagnostics) diluted at 
1:2000 with 1% blocking reagent in P1 for 30 min. After rinsing with P1 the membrane was 
equilibrated with buffer P3 and finally washed with 1:50 diluted NBT/BCIP stock solution 
(Roche Diagnostics) until color development. For gel electrophoresis and blotting, 200 ng of 
the probes was loaded on a 1% denaturing formaldehyde agarose gel in 1× MOPS and run at 
80 V for 1.5 h. After the run, gel and membrane were shaken in DEPC-H2O for 5 min. 
Capillary transfer was carried out with 20× SSC overnight. Nucleic acids were fixed by UV 
crosslinking. Subsequently, the membrane was incubated with the AP-labeled anti-DIG Ab 
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applying the same procedure as for dot blot. Lengths of the probes were compared with 
control RNA (760 nt, Roche Diagnostics). 
 
In situ hybridization protocol 
Sections were cut at 4 μm, mounted on Super Frost Plus slides (Menzel-Gläser, Germany) and 
dried overnight at 42 °C. After dewaxing and rehydration, the sections were fixed with 4% 
PFA and 0.1% glutaraldehyde in 1× PBS. The following steps were carried out with DEPC-
treated solutions in a humified chamber. To denaturate proteins, the sections were digested 
with 0.02% proteinase K in 20 mM Tris–HCl, pH 7.4, 2 mM CaCl2 for 10 min at 37 °C. To 
reduce background, the sections were treated with 1.5% triethanolamine and 0.25% acid 
anhydride for 10 min at room temperature. The slides were incubated with 50 μl 
prehybridization solution per section for 3–4 h at 54 °C. Hybridization was carried out 
overnight at 54 °C with 30 μl of hybridization buffer containing 10 ng of sense or antisense 
probe previously denaturated for 5 min at 85 °C. Slides were washed for 15 min at room 
temperature in 2× SSC, and for 30 min at the specific hybridization temperature at descending 
concentrations of SSC (2, 1, 0.5, and 0.2×). Sections were incubated with the DIG AP-
coupled Ab diluted 1:4000 in 1% blocking reagent (Roche Diagnostics) in buffer P1 for 1 h at 
room temperature in the dark. After washing twice in P1 for 15 min, the sections were treated 
with buffer P3, 5 mM levamisole and NBT/BCIP stock solution (Roche Diagnostics). The 
color development was carried out overnight at room temperature. The reaction was stopped 
by rinse of the slides in tap water for 15 min. Sections were mounted with glycergel. 
 
Immunohistochemistry  
Sections were cut at 4 μm, mounted onto glass slides (Menzel-Gläser), and dried overnight at 
42 °C. After dewaxing and rehydration, they were used for immunohistochemistry. To reduce 
unspecific-binding sections were treated with PBS (pH 7.4) containing 2% bovine serum 
albumin (BSA) for 30 min at room temperature. The sections were incubated overnight with 
the rabbit antiserum 116 (Reinecke et al., 1997; Schmid et al., 1999) diluted at 1:400 and 
washed repetitively in PBS. The IGF-I antiserum was detected by incubation with biotinylated 
goat anti-rabbit IgG (Bioscience Products, Emmenbrücke, Switzerland, 1:100) for 30 min at 
room temperature. After repetitive rinse in PBS, the sections were incubated with 
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streptavidin–fluorescein–isothiocyanate (FITC) (Bioscience Products, 1:100) for 30 min at 
room temperature in the dark. Specificity of the reactions obtained was tested using the 
following controls: (1) Replacement of the primary antiserum by non-immune rabbit serum. 
(2) Pre-absorption of the primary antiserum with recombinant human (h) IGF-I, hIGF-II, 
porcine insulin (kind gift of Prof. J. Zapf, Zürich) or the peptide used for immunization (40, 
400 μg peptide/ml diluted antiserum).  
 Photomicroscopy was performed with a Zeiss Axioscope using the Axiovision 
software 3.1. (Zeiss, Zürich, Switzerland). 
 
 
Results 
 
Specificity of detection systems 
The reaction properties of IGF-I antiserum 116 diluted at 1:400 (Fig. 1A) were tested by 
preabsorption with IGF-I and IGF-II. While the immunoreactions were extinguished after 
preabsorption with 40 μg IGF-I/ml (Fig. 1B) they still were present after pre-absorption with 
400 μg IGF-II/ml (Fig. 1C). Thus, the reactions obtained were specific for IGF-I. 
 In situ hybridization with the antisense and sense probes specific for tilapia IGF-I 
mRNA revealed that hybridization with the antisense probe (Fig. 1D) resulted in positive 
responses, whereas no signal was obtained in the negative control (Fig. 1E). 
 
Male gonad 
Gonad anlagen were first detectable at 7 DPF. At 7 DPF, IGF-I mRNA was first detected in 
the developing male gonad where it was present only in somatic cells but not in primordial 
germ cells (Fig. 2B). At  9 DPF, IGF-I immunoreactivity was also observed in somatic cells 
(Table 1). Starting at 7 DPF, IGF-I peptide but no IGF-I mRNA was observed in primordial 
germ cells (Figs. 2A and B). The exclusive occurrence of both IGF-I mRNA and peptide in 
somatic cells persisted until around 51 DPF, as representatively shown for 29 DPF (Figs. 2C 
and D). From 51 to 53 DPF on (Table 1), IGF-I mRNA (Fig. 2F) and immunoreactivity (Fig. 
2E) were present in both somatic and germ cells. In adult testis, IGF-I mRNA and peptide 
occurred mainly in spermatogonia and spermatocytes and in Leydig cells (Figs. 2G and H). 
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Female gonad 
Gonad anlagen were detectable from 7 DPF. In the developing female gonad, IGF-I mRNA 
was detected in somatic cells at 7 DPF (Table 1) followed by IGF-I peptide at 10 DPF (Fig. 
3A). In contrast, only IGF-I immunoreactivity was found in primordial germ cells starting at 7 
DPF (Table 1), as representatively shown for 10 and 12 DPF (Figs. 3A and C) while IGF-I 
mRNA was still exclusively present in somatic cells (Figs. 3B and D). At 29 DPF, IGF-I 
mRNA (Fig. 3F) in addition to IGF-I peptide (Fig. 3E) appeared in female germ cells. In the 
adult ovary (Figs. 3G–I), the expression of IGF-I varied between the different maturing 
follicle stages. Both IGF-I mRNA and IGF-I immunoreactivity were present in primary and 
previtellogenic oocytes. In oocytes of the later stages no IGF-I mRNA but occasionally IGF-I 
peptide (Fig. 3G) was detected in the cell periphery. Around vitellogenic oocytes and oocytes 
at the lipid stage, IGF-I expression was observed in numerous granulosa (Figs. 3G–I) and 
occasionally also in theca cells (Fig. 3H). 
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Fig. 1 Specificity of immunofluorescence (A–C) and in situ hybridization (D and E). (A–C) 
Pre-absorption experiment with antiserum (AS) 116 diluted at 1:400 on three consecutive 
sections of adult tilapia ovary. The first section (A) is incubated with AS 116, the second (B) 
with AS 116 preabsorbed with 40 μg IGF-I/ml, and the third (C) with 400 μg IGF-II/ml. 
While the immunoreactions are abolished after pre-absorption with IGF-I (B) they still are 
present after pre-absorption with IGF-II (C) 450×. (D and E) In situ hybridization of adult 
tilapia testes on two adjacent sections with an IGF-I antisense probe (D) and an IGF-I sense 
probe (E). Hybridization with the antisense probe specific for tilapia IGF-I mRNA shows 
positive responses (D), whereas no signal is present in the negative control (E). 800×. 
 
 
 
 
 
 
 
 
   89
 
 
Fig. 2 IGF-I immunofluorescence (A, C, E, and G) and in situ hybridization (B, D, F, and H) 
in the early developing and adult male gonad. (A and B) At 7 DPF, in primordial germ cells 
(double arrows) only IGF-immunoreactivity (A) but no IGF-I mRNA (B) is present. IGF-I 
mRNA occurs in somatic cells only (arrow). (A and B) 800×. ( C and D) At 29 DPF, still the 
primordial germ cells (double arrows) show only IGF-I immunoreactivity (C) while IGF-I 
mRNA is present in somatic cells (D, arrow). (C) 400×, (D) 480×. (E and F) At 52 DPF, both 
IGF-I peptide and mRNA occur in somatic cells (arrows) but in the spermatogonia (double 
arrows) in addition to IGF-I peptide (E) also IGF-I mRNA (F) is detected. (E) 500×, (F) 600×. 
(G and H) Adult testis. Numerous spermatogonia and spermatocytes exhibit IGF-I peptide and 
mRNA. Furthermore, IGF-I peptide (G) and mRNA (H) occur in Leydig cells (arrows). (G) 
700×, (H) 600×. 
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Table 1 First appearance of IGF-I peptide (immunofluorescence) and IGF-I mRNA (in situ 
hybridization) in the developing male and female gonads 
 
 
 
 
 
 
_________________________ 
Fig. 3 IGF-I immunofluorescence (A, C, E, G, and H) and in situ hybridization (B, D, F, and 
I) in the early developing and adult female gonad. (A and B) At 10 DPF, in primordial germ 
cells (double arrows) IGF-I peptide (A) but no IGF-I mRNA (B) is present. IGF-I mRNA is 
found in somatic cells only (B, arrow) which also exhibit IGF-I peptide (A, arrow). (A) 500×, 
(B) 700×. (C and D) At 12 DPF, still in the primordial germ cells (double arrows) only IGF-I 
immunoreactivity (C) is present while the somatic cells also exhibit IGF-I mRNA (D, arrow). 
(C) 900×, (D) 700×. (E and F) At 29 DPF, both IGF-I peptide (E) and mRNA (F) occur not 
only in somatic cells (arrow) but also in oogonia (double arrows). (E) 800×, (F) 600×. (G–I) 
Adult ovary. IGF-I peptide (G and H) and mRNA (I) occur in cells of the granulosa (arrows). 
Furthermore, the presence of IGF-I peptide in the cell periphery of a vitellogenic oocyte (G, 
arrowhead) and in theca cells (H, double arrows) is shown. (G) 250× (H) 700×, (I) 400×. 
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Discussion 
 
By the use of molecular biological techniques, both IGF-I (Duan et al., 1995; Duguay et al., 
1996; Greene and Chen, 1997; Deane et al., 2003) and its receptor, the IGF-1R (Greene and 
Chen, 1999; Ayaso et al., 2002), have been detected in embryos of several fish species. These 
results indicate that the important components of the IGF system exist during early 
development and, thus, suggest a high organizational impact of IGF-I during teleost ontogeny. 
Our results showing the presence of IGF-I mRNA and/or peptide in the early developing 
gonad of tilapia strengthen this hypothesis.  
 Both in males and females, IGF-I mRNA and peptide appeared in somatic cells of the 
early gonad anlage already at 7 DPF and 9–10 DPF, respectively. Because at this stage the 
gonad anlage is still undifferentiated IGF-I in the somatic cells may be of crucial importance 
in further gonad development and differentiation. The very early expression of IGF-I in 
somatic cells may well be under the control of GH. In rainbow trout, GH was expressed 
immediately after hatching prior to the formation of the pituitary gland indicating the 
expression of GH in extrapituitary sites during early development (Yang et al., 1999; Deane et 
al., 2003) that contrasts the situation in adult fish (Caelers et al., 2005). In contrast to somatic 
cells, in male and female primordial germ cells only IGF-I peptide but no IGF-I mRNA was 
detected before 29 DPF in females and 51 DPF in males. On the one hand, IGF-I mRNA may 
have been under the detection level of our in situ hybridization. On the other hand, the 
observations may suggest that the primordial germ cells themselves do not produce IGF-I 
during the first weeks of development. In this case two possibilities apply to explain the 
presence of IGF-I: IGF-I may originate from somatic cells and be transferred to the primordial 
germ cells or it may be of maternal origin. In female germ cells, IGF-I mRNA and peptide 
were detected at 29 DPF while in male germ cells both IGF-I peptide and mRNA appeared 
not before 51–53 DPF. In the tilapia O. niloticus, the first meioses in the ovary occur around 
28 DPF and in the testes around 52–53 DPF. Therefore, the appearance of IGF-I in the germ 
cells may be linked to the onset of meiosis.  
 The expression of IGF-I mRNA in isolated trout spermatogenic and Sertoli cells (Le 
Gac et al., 1996) is consistent with the presence of IGF-I-immunoreactivity in tilapia 
spermatogonia and spermatocytes as shown here and in Sertoli cells (Reinecke et al., 1997). 
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In agreement with the potential auto/paracrine function of IGF-I, the IGF-1R has been 
identified in trout testis, where it was probably located at spermatogonia and Sertoli cells (Le 
Gac et al., 1996). In addition, the present study shows that in fish testis IGF-I is produced in 
Leydig cells as it is in mammals (Lin et al., 1990) where it is thought to be a critical autocrine 
and/or paracrine factor in the control of adult Leydig cell numbers and function, especially in  
steroidogenesis (Wang and Hardy, 2004). It is reasonable to assume that IGF-I in fish testis is 
also involved in the synthesis of male sex steroids.  
 Several studies indicate further physiological roles of IGF-I in adult fish male gonad. 
In Japanese eel cultured testes, IGF-I stimulated all stages of spermatogenesis induced by 11-
ketosterone (Nader et al., 1999). In rainbow trout, the amount of testicular IGF-I increased 
after GH-treatment (Le Gac et al., 1996; Biga et al., 2004) which is compatible with the 
presence of GH receptors in trout testis (Le Gac et al., 1996). Not only GH but also IGF-I 
stimulated the incorporation of thymidine into spermatogonia and primary spermatocytes 
from cultured spermatogenic rainbow trout testis (Loir and Le Gac, 1994; Loir, 1999) that in 
gilthead seabream have been shown to exhibit the IGF-1R (Perrot et al., 2000). Based on 
these data it can be assumed, that IGF-I serves as paracrine/autocrine regulator of fish 
spermatogenesis thereby interacting with steroid hormones. Furthermore, IGF-I likely 
mediates the action of GH on the male gonad (Biga et al., 2004).  
 Some in vitro studies indicate different physiological roles of IGF-I in fish ovary. IGF-
I stimulated thymidine incorporation into goldfish vitellogenic follicles (Srivastava and Van 
der Kraak, 1994) and induced final oocyte maturation in red seabream (Kagawa et al., 1994). 
IGF-I increased germinal vesicle migration and breakdown, a marker for resumption of 
meiosis, in oocytes of ovarian fragments of striped bass, Morone saxatilis (Weber and 
Sullivan, 2000). The density of gap junctions between granulosa cells and between granulosa 
cell and oocytes—which both are rare in incompetent follicles—was markedly increased by 
IGF-I in red seabream (Patino and Kagawa, 1999). In summary, the above studies indicate 
that IGF-I promotes follicle cell proliferation and oocyte maturation in ovary.  
 IGF-I likely also plays a role in the regulation of ovarian steroidogenesis, because it 
inhibited steroid production (testosterone, 17α-hydroxyprogesterone) by the theca cells and 
stimulated steroid production (17β-estradiol, 17α, and 20β-dihydroxy-4-pregnen-3-one) by 
the granulosa cells in the preovulatory coho salmon ovary (Maestro et al., 1997b). Similarly, 
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estrogen and progesterone biosynthesis were differentially regulated by IGF-I in cultures of 
common carp ovarian follicles (Behl and Pandey, 1999). In agreement with the potential 
physiological role of IGF-I in the female gonad, the IGF-1R was localised at granulosa and 
theca cells of Coho salmon (Maestro et al., 1997a) and in gilthead seabream additionally at 
previtellogenic oocytes (Perrot et al., 2000).  
 The above described in vitro actions of IGF-I on oocyte proliferation and maturation 
as well as on steroid synthesis under physiological conditions may well be exerted by 
circulating (liver-derived) IGF-I, but further potentially paracrine acting candidates are the 
granulosa cells. These have been shown to produce IGF-I in red seabream (Kagawa et al., 
1995), gilthead seabream (Perrot et al., 2000) and tilapia (Schmid et al., 1999, this study). 
Whether these actions are under the control of GH at present is unclear, however, an increase 
of IGF-I in the gonad after GH application has been shown in rainbow trout (Biga et al., 2004) 
 IGF-I mRNA was further present in young and previtellogenic oocytes as shown here 
but did not occur in oocytes at later stages of development (Schmid et al., 1999; Perrot et al., 
2000, this study). Thus, the intraovarian IGF-I production seems to switch from the young 
oocyte to the surrounding follicle cells during development (Schmid et al., 1999). 
Occasionally, in the present study IGF-I peptide was also observed in mature oocytes. This 
may have been delivered by the surrounding granulosa cells. However, another possibility 
also applies. In unfertilized eggs of seabream a weak expression of IGF-I mRNA has been 
reported (Greene and Chen, 1997, Perrot et al., 1999) while no IGF-I mRNA was detected in 
unfertilized eggs of rabbitfish (Ayson et al., 2002). Thus, mature oocytes may transiently 
express IGF-I and store the hormone for later use. 
 In the Japanese quail, IGF-I has been shown to act not only as endocrine but also as 
paracrine/autocrine regulator of gonadal growth and differentiation (Fu et al., 2001) while 
experimental data on a role of IGF-I in gonad differentiation in bony fish are lacking to date. 
However, the present study by showing distinct and time-dependent IGF-I production sites in 
male and female tilapia gonads during ontogeny suggests a similar role for IGF-I also in fish 
gonads. 
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